A Study on Madhumegam by Shivasubramaniam, S
 
A STUDY ON 
MADHUMEGAM 
 
Dissertation submitted to 
THE TAMILNADU DR. M.G.R MEDICAL UNIVERSITY 
Chennai-32 
 
 
For the partial fulfillment of the requirements to the Degree of 
DOCTOR OF MEDICINE (SIDDHA) 
(Branch I – Pothu Maruthuvam) 
 
 
 
 
 
 
 
DEPARTMENT OF POTHU MARUTHUVAM 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
PALAYAMKOTTAI – 627 002. 
 
APRIL – 2013 





ACKNOWLEDGEMENT 
First of all I wish to express my gratitude to My Parents, who 
showed me this colourful world and for their sacrifice and best wishes. 
I express my Mellipluous thanks to the ‘Siddhars’ who are our 
preaches. 
I wish to thank the esteemed Vice-Chancellor of the TamilNadu  
Dr. M.G..R. Medical University, Chennai for permitting me to undertake 
this study, and The Special commissioner, Directorate of Indian 
Medicine and Homeopathy, Chennai who flagged my dissertation with 
cheer. 
I sincerely extend my gratefulness to the Joint Director of Indian 
Medicine and Homeopathy for giving due recognition for my dissertation 
work. 
I sincerely thankfull of our principal Dr. N. CHANDRA MOHAN 
DOSS M.D.(S), and Vice Principal Dr. S. SOUNDARAJAN M.D.(S), 
Government Siddha Medical college, Palayamkottai, for granting 
permission and providing the necessary infrastructure for this work. 
Words seem to inadequate to express my gratitude to professor 
Dr.S.Mohan M.D.(S) Head of the Post Graduate Department of Pothu 
Maruthuvam, Govt. Siddha Medical College, Palayamkottai, for his 
valuable suggesstions at every step of my dissertation work and have 
been provided very good guidance during this study for which I deeply 
thank him. 
I express my sincere thanks to Prof.Dr. R. Thangamoney 
M.D(S),  Former  Head of the Post -Graduate Department of Pothu 
Maruthuvam for his excellent guidence and encouragement, right from 
the time of choosing this topic for my study. 
I express my whole hearted  thanks to Dr. A. Manoharan M.D(S) 
Reader, Post graduate department of pothu maruthuvam for his excellent  
guidance at every step of my dissertation work. 
I express my thanks to Dr. S. Justus Antony M.D.(S), Asst. 
Lecturer, Post Graduate Department of Pothu Maruthuvam, Government 
Siddha Medical College, Palayamkottai for his valuable guidance and 
timely help in the completion of this dissertation. 
I express my thanks to Dr. G. Subash Chandran M.D(S) Ph.d 
Former Asst. Lecturer, post Graduate Department of Pothu Maruthuvam, 
Government Siddha medical college,Palayamkottai.  
It is my duty to place a record of my profound sense of gratitude to 
Prof. Dr. Neelakandan, M.D., HOD of Modern Medicine, Government 
Siddha Medical College, Palayamkottai, for his unstained encouragement 
and most valuable guidance to undertake this dissertation study. 
 
 
I express my thanks to Dr. Kaniraja M.D.,(s) HOD of Sirappu 
Maruthuvam & Dr. Aathinarayanan, M.D.,(s) HOD of Aruvai 
Maruthuvam  Government  Siddha  Medical College, Palayamkottai. 
I express my thanks to Mr. M.Kalaivanan M.Sc.,M.Phil., HOD, 
Department of Pharmacology, Government Siddha Medical College, 
Palayamkottai. 
I am also thankful to Mrs.N.Nagaprema M.Sc., M.Phil. HOD of 
Biochemistry and other staffs in the Department of Bio-Chemistry, 
Government Siddha Medical College, Palayamkottai. 
I should not forgot to express my gratefulness to Mrs.T.Poongodi 
M.A.M.L.I.S., Librarian, Government Siddha Medical College, 
Palayamkottai for her invaluable help. 
I     Sicerely thank my Dear friends and my colleagues and other 
staff  members who helped me  during this whole period.       
And my great thanks to Broad-Band Net Cafe for their sincere 
and kind cooperation to complete this work successfully.          
       
CONTENTS 
SL.NO. TITLE NAME PAGE NO. 
 ACKNOWLEDGEMENT  i 
1 INTRODUCTION 1 
2 AIM AND OBJECTIVES 3 
3 ABSTRACT  4 
4 REVIEW OF LITERATURES  
 A. SIDDHA ASPECT 
B. MODERN ASPECT 
5 
34 
5 RESULTS AND OBSERVATIONS  79 
6 DISCUSSION 91 
7 SUMMARY 98 
8 CONCLUSION  100 
9 ANNEXURE  
10 A. PREPARATION AND PROPERTIES OF 
TRIAL MEDICNES  
B. BIO-CHEMICAL ANALYSIS 
C. PHARMACOLOGICAL ANALYSIS 
D. PROFORMA OF CASE SHEET  
 
101 
105 
108 
128 
11 BIBLIOGRAPHY   
  
INTRODUCTION 
Siddha system is considered to be one of the ancient system of 
medicine in the world.  Siddha is a complete holistic medical system that 
has been practiced in India for two thousand years and above.  
This system was formulated and established by the eminent 
spiritual power called siddhars and hence the name siddha medicine.  The 
medicine were prepared by the various type of herbo – mineral 
formulations.  
Siddha system emphasizes not only a healthy body and it regulate 
sound mind and soul.  
In the recent years, India has witnessed a rapidly exploring 
epidemic of diabetes.  Indeed, India today leads the world with its largest 
number of diabetic people in any given country.  WHO estimates that 
there are 32 million people with diabetes in India in 2000, which is 
projected to rise to 80 million by the year 2030. Increase in prevalence is 
rapid in urban areas from 2% in 1970s to 12% in 2000 and in rural areas 
also it is now beginning to increase.  
According to WHO recent estimates indicate there were 171 
million people in the world with diabetes in the year 2010 and this is 
projected to increase to 366 million by 2030. Diabetes is a major threat to 
global public health that is rapidly getting worse, and the biggest impact 
is on adults of working age in developing countries.  
World Diabetes Day, a joint IDF-WHO day of global activities 
which takes place on November 14
th
 each year to raise awareness of 
different aspects of diabetes and its complications.  
The Siddhars explained 20 types of pramega noi.  Its diagnosis is 
based on tridhosham and panchapootham.  It is described on the basis of 
colour, consistency, taste, smell, weight, sedimentation etc.  
Madhumegam is a chronic metabolic disorder commonly known as 
“Neerizhivu” characterized by increased and frequent urination, which is 
sweet in odour, resulting in gradual diminition of udalthathus.  
In the book of Theraiyar karisal urinary diseases are classified into 
two types.  
1. Neerinai perukkal noi (Neerizhivu)  
2. Neerinai arukkal noi 
In my dissertation “Neerizhivu” is coming from the neerinai 
perukkal noi.  The present study is limited to the specific type of 
madhumegam or enippu neer which is characterized by polyuria 
containing sugar.  
The evidence or proof for this disease has been explained by “Yugi 
Munivar” in the book of “Yugi Vaidhya Chinthamani 800”.  
The Egyptian papyrus of Ebors (1500BC) has mentioned the 
malady associated with polyuria.  The Greeks who know about its 
prominent manifestation of persistent polyuria named the disease 
Diabetes which means passing urine like a fountain or through siphon.  
Mellitus means sweetness.  
The signs and symptoms of  “Madhumegam” is correlated with 
that of “Diabetes mellitus” in modern science is DM.  
In this study along with siddha aspects the criteria in the modern 
medicine for this disease had also been included with the available 
facilities in the post-graduate department an attempt has been made to 
install the pharmacological and therapeutical role of siddha medicines to 
alleviate the disease madhumega noi.  
 AIM AND OBJECTIVES 
Aim: 
 Preclinical and clinical study on Madhumegam (Type 2- 
DIABETES MELLITUS) and the drug of choice is Neerizhivu 
Chooranam.  
Objectives 
1. To evaluate the efficacy of siddha formulation Neerizhivu 
Chooranam for decreasing the blood glucose level in the treatment 
of Madhumegam.  
2. To Prepare the trial drug Neerizhivu Chooranam as per Siddha 
literature (The Pharmacopoeia of Siddha Research Medicines - 
Specific Medicine) and to analysis the qualitative and quantitative 
constituents present in the trial drug. 
3. To establish the toxicological profile by performing acute oral 
toxicity studies and sub chronic toxicity studies on mice and rats 
following who guidelines. 
4. To have a notion of the range of the diseases with sex, age, 
occupation, social status, diet, hereditary, and paruvakaalam., etc. 
5. To study the Safety and efficacy of the test drug through an open 
clinical trial.  
 ABSTRACT 
Since the commonest disease in the society, number of  sufferers 
increasing day by day. So that the author had chosen the disease, 
“Madhumegam” for his dissertation work.  
20- Out patients and 20  In patients of either sex were selected for 
the study at PG-I Pothumaruthuvam department and administered with 
the trial medicine.  
The trial drug “Neerizhivu hoornam” 2 gm two times a day with 
butter milk was administered during the whole study period. 
The trial medicine was subjected to Biochemical and 
pharmacological analysis.At the end of the trial study, the majority of the 
patients showed good results. 
 REVIEW OF LITERATURES 
SIDDHA ASPECT 
MADHUMEGAM 
Siddha system of medicine is an ancient system and it deals not 
only with the body of man but also with the inner soul.  
According to siddhars the imbalance of tridhosha causes totally 
4448 diseases to human being. Among  them megarogam is considered to 
be the emperor of diseases. 
‘Mkg;gh kdpjh; nra;j fd;kj;jhNy 
mufuh Nkfnkd;w uhrhthNy“ 
-mfj;jpah;.; ;; ;; ;  
Madhumegam has been described by many siddhars in their texts. 
The aetiology, pathogenesis, classification, features, diagnosis and 
prognosis have been dealt in detail in these texts.   
Synonyms of Madhumegam :-(verupeyar) 
Neerizhivu, vegumoothiram, madhuprameham,  inippuneer, 
meganeer, Thiththipuneer. 
Definition:- (Iyal)  
It is a clinical condition characterized by frequent passage of urine 
more than the normal, resulting in deterioration and diminution of seven 
udal thathus.   
‘,dpg;ghd ,dpg;gy;y < te;jhLk; 
xU Jsptha; tpl;lhh;ifg; gpzpaha; Njhd;Wk;” 
- FUehb 
The above description quotes that  ant and flies are attracted to the 
site of voided urine and when the urine is heated it gives honey odour.  
‘mz;ikahabf; fbf;F ePhpwq;F  
kbf;fbf;F miuehop jdpNy fhZk; 
ntz;ikahd jbajdpw;whd; gpbf;Fk; 
kpf;fhd rlk; ntSj;J Nkdp fd;Wk;” 
     -a+fp itj;jpa rpe;jhkzp; ;; ;; ;  
ETIOLOGY: (Noivarum vali) 
a) The authentic etiological factors described by various siddhars are as 
follows, 
‘Nfhijah; fytp Nghij 
nfhOj;j kPd; ,iwr;rp Nghij 
ghJtha; nea;Ak; ghYk; 
ghpTld; cz;gP uhfpy;  
Nrhj ghz;LUt kpf;f  
Rf;fpy gpuNkfe;jhd; 
xJ ePhpopT Nru  
Tz;nld mwpe;J nfhs;Ns”  
          -mfj;jpah; 1200; ;; ;; ;  
The above poem quotes that erosive intake of rich food like ghee, 
fish, milk, toddy  and excessive indulgence in sex leads to madhumegam.  
The same also discussed in “Yugi Sinthamani”.  
 ‘cw;gtpf;Fk; ghy; nea;ahy; ,iwr;rp fs;shy; 
Thpiraha; kPd;jd;dha; mUtpUe;j 
kw;gtpf;Fk; gjhh;j;jj;jhy; kJut];jhy; 
ke;jq;fs; jidGrpj;jy; Ntfhg; gz;lq; 
Fw;gtpf;Fk; FSj;j td;d kq;if Nfh\;b  
Fwpj;j epj;jpiu jtph;jy; mf;fpdp ke;jk; 
jw;gtpf;Fe; rhPue;jhd; kpfg;gUj;jw; 
rQ;rye;jhd; kpfg;gaj;jhy; jhpf;Fk; NehNa” 
- a+fp itj;jpa rpe;jhkzp; ;; ;; ;  
Yugimuni in his text attributes this disease due to injudicious diet 
containing rich fat, sweet and also obesity.  Too much of sedentary  
habits without exercise also leads to madhumegam, undue fear, severe 
depression has also emphasized for the development of madhumegam.  
b) Hereditary factors:-   
Statistics indicate that those with family history of diabetes have 
higher (25-35%) risk than those without such background.  
 
‘NgW ,sik ,d;gk; gpzp %g;G rhf;fhL 
MWk; fUtpy; mike;j gb  
Kiw Nfl;fpy; xd;gJ Kaw;rpahy; te;jJ  
Jiw Nfl;fpw fUg;gj;jpw; Wtq;fpa  Nkfq;fs;  
 eiu g+j;j nfhq;ifahs; ehafd; Nkhfj;jhy; 
  kiwNghw;Wq; fUg;gj;jpy; tsh;e;jJ NkfNk”  
                       -jpU%yh; ;;;  
‘cw;wpLk; cyfj;Njhh;f;F  cWgy tpahjpnay;yhk; 
   gw;wpLk; Fzq;fs; jd;id  gfh;e;jJiu nra;aNtz;Lk; 
  xj;jpLk; rddthWk; clYapUdthUk;  
   me;jp khkiyapd; thOk; khKdp tFj;jjhNk”  
-mfj;jpah; FU ehb rhj;jpuk; ; ; ; ;; ; ; ;; ; ; ;  
C) Sexual indulgence:  
‘fd;dp kaf;fj;jhy; fz;bL NkfNk” 
       - ehb E}y; ;;;  
‘fpue;jp Gz;zPud Nkf fPrfndDe; Jd;khhf;fd;  
mUe;jjp vd;Dk;  ghQ;rhyp ad;idia fz;Zw;whNd”  
      -Njud; kUj;;; ;Jtghujk; ; ;; ;; ;  
‘];jphpNghfk; nra;jjpdhy; NtT nfhz;L  
rpuRkl;Lk; nte;JUfp fdNy kPwpf; 
FwpAlNd Nkfe;jhd; nfhLik nra;J  
Fiwe;J tUk;  jhJnty;yhk; Fd;wpg; NghFk;” 
                         -FUehb 
From the above poem, all siddhars attribute diabetes mainly due to 
excessive indulgence in sex which results in depletion of total strength of 
body as a whole, making the individual susceptible to this disease.  
d) Psychomatic factors:-  
Yugimunivar and other siddhars said stress is a great importance to 
psychosomatic factor. All antisocial activities ultimately result in 
subjective guiltiness and psychosomatic stress resulting in disease like 
diabetes, peptic ulcer and hypertension. 
 
‘kjq;nfhz;L nghpNahiu itifahYk; 
khjh; fw;Gepiyik jd;id mopf;ifahYk; 
gjq;nfhz;l rptNahfp rhgj;jhYk;  
gj;Jtif rpNyw;gdq;fs; NkfePuhk;"; 
- a+fp itj;jpa rpe;jhkzp; ;; ;; ;  
e) Kanma Noi:- 
 ‘jhNd g+Ut tpjpajdhw; rhUk; gpzpfsy;yhky;  
khNdhh;  tpopahh; Ntl;ifapdhy; tUe;Jk; gpz;Zk; grpahNy 
jhNd nghWj;J cz;ifapdhy; jhfe; jd;dhy; kpfr;rhh;e;J  
jhNd fkyk; Gz;zhfpr; nra;Ak; gpukpar; nray;jhNd”  
-Njiuah;thflk;; ;; ;; ; 
 ‘Mkg;gh kdpjh;nra;j fd;kj;jhNy  
  mufuh Nkfnkd;W uhrhthNy  
 fhkg;ghy; tPjijjhw; tUq;fd;kj;jhNy  
  iff;flq;fh Neha;fs; tUq;fd;kj;jhNy  
 Nghkg;gh Nkfk; te;j fhuze;jhd;” 
     -mfj;jpah; fd;k fhz;lk; ; ; ; ; ;; ; ; ; ;; ; ; ; ;  
In the views of Theraiyar, Agasthiar, Thirumoolar, madhumegam 
also occurs as a result of bad deeds committed in his or her past.(or their 
previous births) 
Noi Enn (Classification):-  
 ‘my;Y nkd;Nw NkfkJ ,uz;Lgj;J  
kfpo;e;J eP NfSnkd;W trdpj;jhNu” 
      - a+fp itj;jpa rpe;jhkzp; ;; ;; ;  
‘fopAk; thjk; ehd;fhYk; fhAk; gpj;jk; MwhYk;  
RopAk; Nrj;Jkk; gj;jhYk; nrhy;Yk; ehyQ;rha;j;  
topAk; thjk; ehd;fhNk khwh jtpo;jhy; jd;dhNy  
nghopAk;  thjk; epy;yhJ NghNk kUe;ijg; ngha;nadNt” 
-Njiuah; thflk;.; ;; ;; ;  
ePhpopT Nehia NkfePh;Neha; vd;W toq;FtJk; mJ 
tspf;Fw;wj;jhy; gpwg;gd ehd;F> mow;Fw;wj;jhy; gpwg;gd MW> 
Iaf;Fw;wj;jhy; tUtd gj;J Mf nkhj;jk; ,UgJ ghpTfnsd NkfePh; 
Nehia tFj;Js;shh;fs;.  
tspf;Fw;wj;jhy; tUk;  NkfePh; ; ; ; ; ; P ;; ; ; ; ; P ;; ; ; ; ; P ;  Neha;:;;;  
nghJf;FwpFzk;:; ;; ;; ;  
 nghJthf if> fhy;> fz;> cly; ,it moy; Nghy; vhpAk;> 
ehtwSk;> gy;> eh> njhz;il ,it fWj;J ,Uf;Fk;. Ngr;Rtd;ik 
FiwAk;> fz;fs; Nky;Nehf;Fk;> mbf;fb grpAk;> ePh;Ntl;ifAKz;lhFk;>  
cly; KOikAk; typ vLf;Fk;.  
tspNkfePh;fs;:   P ; ;P ; ;P ; ;  
4 tifg;gLk; 
 nea;kzePh; 
 gRePh; kzePh; 
 Cd; kzePh;  
 ,skwpf; nfhOg;G kzePh;  
moy; Fw;wj;jhy; gpwf;Fk; NkfePh; Neha;fs;:; ; ; ; ; ; P ; ; ;; ; ; ; ; ; P ; ; ;; ; ; ; ; ; P ; ; ;  
 ‘mwpaNt gpj;jrykhWNk jhd; 
  mq;fkjpw; nra;fpd;w Fzj;ijf; Nfsha;  
 jwpaNt cly;tw;wp vhpTz;lhFk; 
  rlj;jpYe;jhd; ePhpYe;jhd; ftpr;Rz;lhFk;  
 njwpaNt rPg;NghYq; fw;whio NghYe;  
  Nry;NghYe; Njd;NghY ehw;wKz;lhk;  
 ntwpaNt gPrj;jpw; Nfhrj;jpy; Fj;jy; 
  kpFkPuy; ehgpapYk; Ntf;fhlhNk” 
  
 ‘Ntf;fha; tpuzKz;lha; tha;jhdhYk; 
   tpf;fNyhL mUjpaha;r; RuKz;lhFk;  
  jPf;fhlha; Njfe;jhd;  fplf;nfhl;lhJ  
   jpaf;fnkhL %h;r;irAz;lh kaf;fkhr;Nr  
  rhf;fhlha; ehtwSq; fz;zPh; jhfQ;  
  rhj;jpnahU  rhPunkyhe;  jsh;r;rp ahFe; 
   jhf;fhlha; kyrye;jhd; kpfTz;lhFe; 
  jhf;fhlha; kyrye;jhd; kpfTz;lhFQ; 
   rkFze;jhd; gpj;jry khWkhr;Nr” 
      -a+fpitj;jpa rpe;jhkzp; ;; ;; ;  
nghJ FwpFzq;fs;:; ;; ;; ;  
gpj;j Fw;wj;jYz;lhFk; NkfePh; Nehapy; cly; KOikAk; ntg;G 
cz;lha; vhpr;ry;> cly; twz;L RUq;fy;> cly; tpah;j;jy;>  
rpWePh; Njd;kzj;Jld; ,Uj;jy;> ePh;g;Gio> tpiu> <uy;> ce;jp> 
,t;tplq;fspy; Ntf;fhL cz;lhjy; Kjypa FwpFzq;fis 
Njhw;Wtpf;Fk.;  
gpj;jNkfePh; Neha;f; P ; ;; P ; ;; P ; ; s; ;;;  
,J MW tifg;gLk;; ;; ;; ; 
 ahid nfhOg;G kzePh; 
 fw;whio kzePh; 
 Rz;z kzePh; 
 jpj;jpg;G ePh; 
 gspq;F ePh; 
 Kaw;FUjp ePh;  
Iaf;Fw;wj;jhy; gpwf;Fk; NkfePh;Neha;fs;:; ; ; ; ; ; P ; ; ;; ; ; ; ; ; P ; ; ;; ; ; ; ; ; P ; ; ;  
‘jrkhd gj;Jf;Fq; Fzj;ij Nfsha; 
  rhPue;jhd; gUj;JNk ntSg;Gz;lhFk; 
 mrkhd jpdTz;lh kbf;fbf;F 
  frkhd tpUkYld; Nfhio Az;lhq; 
 fdthpth ahahr KoiyahFq;  
  Frkhd Fzq;fisnay;yhk; rpNyl;Lke; jd;dpy; 
 nfhba ryf;Fznkd;W $wpdhNu”. 
      -a+fpitj;jpa rpe;jhkzp; ;; ;; ;  
nghJFwpFzk;:;;;  
Iaf;Fw;wj;jpdhy; cz;lhFk; NkfePh; Neha;fspd; nghJthf cly; 
ntSj;jy;> cly; gUj;jy;> nrhwprpuq;F> jpdT Kjypad cz;lhjy;> 
mbf;fb md;dKk; ePUk; kpFjpahf mUe;jy;> ,Uky;> njhz;ilapy; 
Nfhio fl;ly;> clnyhpr;ry;> ePh;Ntl;if Kjypa  FwpFzq;fs; 
cz;lhFk;.  
 
IaNkfePh; Neha;fs;:P ; ; ;P ; ; ;P ; ; ;  ,J gj;J tifg;gLk;; ; ;; ; ;; ; ; 
 epzk; kpjf;Fk; ePh; 
 njspePh; 
 %is ePh; 
 ,sePh; 
 fs; ePh; 
 Rf;fpy ePh; 
 fOePh; 
 Njd;ePh; 
 cg;GePh; 
 ,iwr;rp ePh; 
Agasthiyar kanmakaandam 300:  
 ‘eykhd Ngh;njhLj;J nrhy;yf;NfS 
  ey;y nfe;jd;  cUj;jpuhq;fd;; ,e;jpufz;b 
 Fykhd rNyhj;jpud; gr;irtz;zd; 
  nfhba Urpfd; rpyhq;fd;     nuj;jtz;zd; 
 ngykhd gPjtz;zd; uj;jpdtz;zd; 
  Ngrhpa  rk;gpuhrd; mde;j ehkd; 
 mde;jNdhL ePyfz;ld; jtstz;zd; 
  mjpgpukd; kJNkfd; mj;jNdhL  
 rpde;jzpf;F vYk;GUf;fp Gl;guhrd;”  
NkfNeha;fs;; ;; ;; ; kzk;;;; Rit  Kf;Fw;wePh; ; ; P ;; ; P ;; ; P ;  
nfe;jd; khk;g+thrk;  Gspg;G thjryk;  
cUj;jpuq;fd; jhok;g+thrk;  ,dpg;G rpNyj;JkePh; 
,e;jpufz;b nrz;gfg+thrk; ehftplUrp rpNyj;JkePh; 
ryNjhj;jpud; Fq;Fkg+thrk; ifg;G Gspg;G  - 
gr;irtz;zd; jirehw;wk;  mjpf jhfk; thjgpj;jePh; 
Urpfd; ghdfk; thrk;  mjpf ifg;G gpj;jePh;  
rpyhq;fd; fhbehw;wk; ifg;G Gspg;G thj ePh; 
uj;jtz;zd;  cjputhrk; ,dpg;G fgePh; 
gPjtz;zd;  cg;Gehw;wk;  cg;G   ngUk;gpj;jePh; 
uj;jpdtz;zd; myupg;g+thrk; -   thjgpj;jePh; 
rk;gpuhrd;  Nfh%j;jpuk;  mjp%j;jpuk;  gpj;jthj ePh; 
mde;jd;  rh;kthrk;  rPdpUrp  fgePh; 
ePyfz;ld;      mjpf%j;jpuehw;wk; vWk;ghpf;Fk;  fggpj;jePh; 
jtstz;zd; fhzhfk;tPRk; rh;f;fiu ,dpg;G fgePh; 
gpukd;   ge;jdthrk;  kpsFciwg;G gpj;jthjePh; 
kJNkfd;  fs;ehw;wk;  Gspg;G   fggpj;jePh; 
mj;jd;  ghy;ehw;wk;  ntz;nza;Urp thjePh; 
vYk;GUf;fp  Rz;zehw;wk; Rz;zUrp  gpj;jePh; 
Gl;guhrd;  ky;ypifg+thrk; fhpj;jy;  gpj;jePh; 
Noi kuri kunangal (clinical features):  
‘rhpahf Nkfj;jhy; mghd thA 
jhd; Giff;F NkNywpf; fghyr;#lhk; 
nghpjhd Nkfj;jhy; mj;jp nte;J 
Nghkg;gh jirnte;J uj;jk; tw;wpg; 
ghpthfpj; jrthAthy; ke;jq;nfhz;L 
ngUe;jPdp kyge;jk; cjhdthA 
thpthfpj; Njfnky;yhk; tplePuhNy 
nka;aope;j Nkfnkd;w jpUgjhr;Nr” 
       -rpj;j kUj;Jtk;; ; ;; ; ;; ; ; 
msT fle;j grp jhfk; vd;Dk; Fwpfisf; fhl;b grp nfhz;l 
msT Grpf;fpDk; cly; td;ik ngUfhJ> ehSf;F ehs; nkyptiljy;. 
 ePh;Ntl;ifiaj; jLf;Fk; nghUl;L gUFk; ePhpd; mstpw;F Vw;g 
rpWePh; ,wq;Fjy;> J}f;fkpd;ik> kdf;fyf;fk;> gpRgpRj;j tpah;it> 
,isg;G  
ngU%r;R kaf;fk; vd;Dk; Kw;Fwpfis fhl;b Neha; td;ikapy; kpFk;. 
Premonitory symptoms :-  
 Thirst  
 Excessive hunger  
 Polyuria 
 Body Pain 
 Tiredness 
 
 Signs and symptoms:- 
 Yugimuni has described the signs and symptoms of madhumegam 
as followed  
‘$whd NkfkJ ,UgJf;Fk; 
Fze;jid rptd;nrhy;y NjtpNfl;f  
jhwhd jhfnkhL Nrhf Nkfe; 
jhpahky; ePhpopjy; ,Uky; %r;R 
MwhdmUrp rj;jp rpj;j gpuik 
mbf;fbf;Fj; jz;zPh; jhdd;dq ; Nfl;ly; 
<whd   ,Lg;Gfs;      fLg;G     fhzy;   
vYk;G ow;wyow;wNyh  nlhpTz;lhFk;”; 
 
‘vhpNthL rhPunky;yh kiwgl;lhw; Nghy; 
vopOlk;G Nehjy; epj;jpiu apy;yhik  
kdJ rQ;ryg;gLjy; fhw;W Ntz;ly; 
nkhpNthL  Nky;%r;R kpfTz;lhjy; 
tpf;fnyhL kaf;fe;jhd; nkj;jf; fhzy; 
njhpNthL Njfnkq;Fk; ntSUz;ljhy; 
Njfnkj;j thNyhgg;gLjy; fhNz” 
 
 ‘jz;ikaha; rye;jhDk; gRg;G kQ;rs; 
jhdpwq;Fk; gPrKk; NfhrKq; fLf;Fk; 
mz;ikahabf;    fbf;F    ePhpwq;Fk; 
mbf;fbf;F miuehop jdpNy jhZk; 
 
‘ntz;ikaha; abajdpw;whd; gpbf;Fk; 
kpf;fhd rlk;ntSj;J Nkdpfd;Wk;  
gz;ikaha;g; gQ;thz;ljdpw; nfhy;Yk; 
gfph;fpd;w kJNkfj;jpd; ghq;F jhNd”  
       -a+fp rpe;jhkzp;;;  
The urine thus passed is cold ,slimy touch, has brownish yellow 
colour, produces white sediments which adhere to the bottom of the 
vessel. The skin is pale and there is generalised tenderness. If it  is 
diagnosed in time and not instituted proper treatment with diet restriction, 
the disease will run a fulminating course.  
 In Agasthiyar Aayulvagadam:  
‘KfNk fhe;jp neQ;Ryh;e;J KWj;J 
KlY eLq;fp efNk gupe;J rPh; nefpo;e;J 
eQ;Rz;lth; Nghy; Njfk; Nrhh;e;J gfYkpuT KUf;fpAly;  
gfWNkdpAk; jsh;e;J kpfNt jhtzKz;lhFk;”  
In this poem burning sensation on hands, legs, Face, dryness of 
mouth, giddiness, general weakness, tiredness, tremors, loss of appetite, 
sweating, pallor of skin are mentioned.  
Avathaigal [Complications Of Madhumegam]: 
‘fhzNt Kjytj;ijr; rhPue; jhDq; 
fdkhfg; gUj;jpWfp ePh;j;J thuk; 
NtzNt Ntz;lhf;fp afyk; gz;Z 
kpf;ftuz; lhktj;ij tpsk;gf; Nfsha; 
%zNt %j;jpug;gP ilAkhr; Rf;y 
KfKOfpj; Nj[Rjhd; kpfNt Fd;Wk; 
ehzNt %d;whF ktj;ijf; Fj;jhd; 
ehtwSk; thAtJ kPWe; jhNd” 
 
‘jhdhd ehytj;ij aq;f jhfQ; 
  rd;dpaJ ghjKz;lh ike; tj;ijj; 
Njdhd ePh; ngUFe; jhJe\;lk;  
epiyahw ktj;ijAlw; fpilnfhs;shJ 
%dhd %h;r;irtU Nko tj;ij 
kpf;ftNuh rfQ;Rthre; Njf rhl;bak; 
Vdhd vl;lht jtj;ij jhNd 
vOfpue;jp gpsit Ae;jhd; kpfTz;lhNk 
cz;lhF nkhd;gjh ktj;ijf; Nfsha; 
cof;fhd tjprhuq; fpUkp Az;lhk; 
gz;lhd gj;jhe;jh itj;ij Nfsha; 
ghukhk; raq;fz;L guj;Jf; NfFk;”. 
     -a+fp itj;jpa rpe;jhkzp; ;; ;; ;  
Yugimuni has described the complications of madhumegam as 
Avathaigal. 
Avathaigal 10:- 
1. First symptom for meha disease is  obesity  and dilatation of urethral 
canal. 
2. Body becomes dry and loses its lusture due to excessive secretion and 
flow of urine mixed with vital fluid (Semen).  
3. Dryness of tongue and distension of abdomen due to formation and 
accumulation of excessive gas.  
4. Delerium (toxic Condition) supervenes following dehydration due to 
excessive elimination of tissue fluid.  
5. Restlessness due to loss of vital fluid in urine.  
6. Breathlessness and restlessness. 
7. Nausea, tastelessness, laboured breathing,  exhaustion.  
8. carbuncle and multiple abscess formation . 
9. Maggot formation and generalised emaciation. 
10. Intractable troublesome, cough with profuse expectoration leading to 
death. 
The above complications occur in undiagnosed and improperly 
treated cases. The complications of madhumegam described in siddha 
text is really correlates with diabetes mellitus in modern medicine. 
Mukkutra Verupadugal:- 
  ‘gfh;gpj;j tpe;ijayhJ Nkfk; tuhJ” 
-Njiuau; ;;;  
  ‘FwpAlNd Nkfe;jhd; nfhLik nra;J 
   Fiwe;J te;J tUe;jhJ nty;yhq; Fd;wpg; NghFk;” 
     -gjpnzd; rpj;jh; ehb E}y; ; ; ; ;; ; ; ;; ; ; ;  
In case of Madhumegam Pitham is affected first and then Vaatham 
is affected. Finally Kabam is affected. So, all the three Uyir Thathus and 
seven Udal thathus are affected. 
Gradually body become emaciated and these are excreted through 
urine.  The severity of  the disease is measured by the functions of three 
dhosha and seven thathus.  
As per siddha system of medicine the body is madeup of 
panchabhoothas. Three Primary naadies idakalai, Pinkalai, Suzhumunai 
respectively combined with abanan, pranan and  smanan. 
 Idakalai   +  Abanan → Vatham 
 Pinkalai  + Pranan → Pitham 
 Suzhumunai  + Samanan →  Kabam 
 Normally these three factors tend to be in their states of 
equilibrium (1:½:¼) but at times they are susceptible to imbalance and 
such alteration leads to disease state.  
Mukkutram:- 
 Vaatham  
 Pitham 
 Kabam  
Vaatham:- 
Vaatham is the primal constituents of living body whose structure 
is vayu + Agayam. It maintains the cohesive unity of the body as a whole. 
Types of Vaatham:- 
Vaatham is just like a Air but it also causes motion energy and 
sensation in the body. It is further divided in to ten types.  
 Pranan 
 Abanan 
 Viyanan 
 Udhanan 
 Samanan 
 Nagan 
 Koorman 
 Kirukaran 
 Devathathan 
 Dhananjeyan 
In case of madhumegam, following types of vatham are affected  
 Abanan  - Polyuria 
 Viyanan  - Burning sensation and numbness over the  
plantar Surface of the foot 
          Udhanan  - thirst, nausea, vomiting 
Koorman  - Disturbances of vision  
Kirugaran  - Excessive hunger, dryness of tongue  
Pitham: 
The main function of pitham which represents agni. It’s function is 
thermo genesis or heat production, metabolism and process of digestion 
etc.   
Types of Pitham: 
It is divided into five types, 
1) Anarpitham: 
2) Ranjaga pitham:- 
3) Pirasaga pitham:- 
4) Sathaga pitham:- 
5) Aalosaga pitham: 
In case of mathumegam following types of pitham are affected 
Anarpitham  - Polyphagia 
Aalosaga pitham - Blurring of vision  
 Kabam: 
The detoriation of the  two main kutram also accompany the kabha 
kutram which structure is Earth + water and is concerned with the 
digestion of food and lubrications of joints etc. 
Types of Kabam: 
It is divided into five types, 
Avalambagam: 
Kilethagam: 
Pothan: 
Tharpagam: 
Santhigam: 
In case of madhumegam following types of kabam are affected 
Kilethagam  - Increased appetite  
Avalambagam - Impaired heart function  
Udal Kattugal:- 
Disturbance in vatham, Pitham and kabam gets reflected on udal 
thathus leading to disease. The seven udal thathus that  supports the body 
in their state of equilibrium are as follows.  
1) Saaram: 
Strengthens the body and mind. 
2) Senner: 
It gives power, knowledge and boldness.  
3) Oon: 
It gives  structures of the body and responsible for movements of 
the body. 
4) Kozhuppu:- 
It lubricates the joints and other parts of the body to facilitate 
functions.  
 5) Enbu: 
It is responsible  for the posture and  movement of the body and 
protect the internal organs.  
6) Moolai: 
It nourishes the bone and gives strength to the body.    
7) Sukkilam/ Suronitham: 
Responsible for reproduction. 
In case of madhumegam all udal kattugal affected  
Saram - Tiredness 
senner - Weakness 
Oon  - Weight loss 
Kozhuppu  - Obese or weight loss 
Enbu  - Joint pain 
Moolai - Affected 
Sukkilam - Excessive flow of urine mixed with vital fluid  
Kosam: 
1) Annamayakosam:-   
Made by 7 udalthathukkal i.e the physical frame maintained by 
food and nourishments. 
2) Piranamayakoam:- 
Piranan + Kanmenthiriyam 
3) Manomayakosam:- 
Manam + Gnanenthiriyam 
4) Vingnanamayakosam:- 
Puddhi + Gnanenthiriyam 
5) AnanthamayaKosam:- 
Piranan + Sulutthi 
 Udal Vanmai: 
 Udal vanmai means the body resistant to a disease because of the 
formation of humoral antibodies that is called immunity. 
Iyarkai vanmai: 
 Natural immunity of the body present in birth onwards. 
Seyarkai vanmi: 
 Improving the health by nutritious food, medicines,  karpams, 
vaccines all fall in to this category of increasing the immunity by human 
measures. 
Kala vanmai: 
Developing the immunity and stamina according to the age of the 
person, season and evironment.  
Piniyarimuraimai (Diagnosis): 
 To deal one disease and confirm what is what, diagnosis is made 
out. It is very helpful to take over. Correct line of  treatment and assess 
the progress of the disease.  
 In siddha medicine the diagnosis is based upon the following 
methods. 
 Poriyal aridhal 
 Pulanal aridhal 
 Vinathal 
 Envagai thervugal  
 Naadi paritchai 
These also comprises some other parameters to confirm the 
diagnosis, These are Thinai, kaalam, Udal vanmai, Mukkutrangal, 
udalkattugal. 
 Poriyal arithal and pulanalarithal: 
Pori is considered as the five sense of perception namely skin, 
Tongue, Eye, Nose, Ear.While  pulan are five objective senses. These are 
Touch, Taste, Vision, Smell, Hearing.  
Gnanendriyam: 
 Organ   Sensory function  
 Mei    Touch 
 Vai    Taste  
 Kan    Vision 
Mooku   Smell 
 Kaadhu   Hearing 
In case of madhumegam, touch (numbness and burning sensation 
over the foot) and vision (Blurring of vision, cataract, glaucoma) affected. 
Kanmendhriyam: 
 Organ   Function  
 Kai    Movements of upper limbs 
 Kaal    Movements of lower limbs 
 Vai    Speaking  
 Eruvai   Defaecation  
 Karuvaai   Reproduction  
Alavai Nool: 
 Alavai methods are very much used for the purpose of diagnosing a 
disease. Among the ten the first three are very important and helpful in 
the examination of patients.  
Kaandal: 
 This disease can be suspected by emacication or obesity,  
collection of large volume of urine, diabetic ulcer etc.  
 Karuthal: 
when the patient complaint of polyuria, polydipisa, polyphagia, 
loss of body weight etc.  
 
Urai: 
‘,Ukpa gpj;jk; thjk; $by; 
   kUT ryNkfk; thUjp NghyhLk; 
  cUtk; NtwhL Kz;lTlw; fha;e;jpLk;  
   cUfNt t+NdhL cwpQ;R ,dpf;FNk” 
        -jpU%yh;;;; 
In addition to the above clinical manifestations the  pithavatham 
nadi felt in the Madhumegam. 
 
Vinathal:- 
It has the procedure for gathering information about the patients 
In madhumegam vinathal is very much useful for 
piniyarimuraimai. 
 
Kaalam: 
The period of human life in 100 yrs this has been divided in to 
three stages. First stage vatha period, Second stage pitha period, third 
stage kabha period. 
 33yrs 4 Months  - Vatham  
  33yrs 4 Months - Pitham 
 33yrs 4 Months - Kabam  
 
 Thinai:- 
Nilam is classified into five types depending on the surrounding 
vegetation. Landscape and ecological state.  
Kurunji  - mountain and its surroundings  
 Mullai  - Forest and its surroundings 
 Marutham  - Field and its surroundings   
 Neithal  - Sea and seashore 
 Paalai   - Desert and its surroundings. 
Madhumegam is prevalent in all types of land.  
Envagai Thervugal:-  
‘md;ghd rhj;jpuq;fs; mwpa Ntz;Lk; 
md;ghd ehbjidg; gpbf;f Ntz;Lk; 
Fd;whd kiyNghd;w ehbnay;yhk; 
Fwpg;Gld; mrhj;jpaKQ; rhj;jpaq;fz;L  
jd;whd ml;ltpj ghpl;ir fz;L 
jf;fhd Fzq; Fwpfs; ahTe; Njh;e;J 
td;whd thflj;jpd; EZf;fk; ghh;j;J 
tskhf gpzpajidj; jPh;g;Nghh; jhNk”  
- a+fp itj;jpa rpe;jhkzp; ;; ;; ;  
 ‘ehb ];ghprk; eh epwk; nkhop tpop 
  kyk;  %j;jpukpit kUj;JtuhAjk; 
 nka;f;Fwp epwe;njhdp tpop ehtpUgha; iff;Fwp” 
       -Njiuah;;;; 
‘juzpAs;s tpahjpjd;id al;lq;fj;jhy; 
  jhdwpa Ntz;LtJ Nanjhntd;dpy; 
 jpuzpa Njhh; ehb fz;fs; rj;NjhL 
  Njfj;jpdJ ghprk;  cUzk; ehf;F 
 apuz ky %j;jpukh tpitfnsl;Lk;  
  apjk; glNt jhd; ghh;j;Jf; Fwpg;Gq;fz;L 
 gUzUshy; ghh;j;Jf; Fwpg;Gq;fz;L  
  gz;G jtwhky; gz;bjh nra;tPNu  
       -Fzthfl ehb  
The unique diagnostic principle in siddha system of Medicine is 
Envagai thervugal 
 Naadi 
 Sparism 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram  
Naadi: 
Naadi is responsible for the existence of life and can be felt one  
inch below the wrist on the radial side by means of palpation with  the 
tips of index, middle and ring finger corresponding to vatham, pitham, 
kabam.  
Normally the three humours vatham, pitham and kabam exist in the 
ratio 1: ½ : ¼ Any variation in these ratio leads to disease and it is 
diagnosed by Naadi. 
Naadi in madhumegam:-  
“,Ukpa gpj;jKk; thjKk;  $by; 
  kUTy Nkfk; thUjp NghyhLk; 
 cUtk; NtnwhU Kz;lTlw; fha;e;jpLk;  
  cUfNt t+NdhL cwpQ;rp ,dpf;FNk’ 
        -jpU%yh;ehb;;;  
The pitha and vatha variation is indicated clinically by excessive 
hunger, thirst, emaciation and passing of large quantities of urine.  
‘,dpf;fpd;w thjj;jpil Nrhpy; Iae;jhd; 
  gdpf;fpd;w fs;Sg; gjdpNghy; ePNuhLk; 
 fdpf;fpd;W Nkdp fiue;J ntSg;NgWk; 
  fdpf;FkJ Nkfe;; jg;NghijahNk  
        -jpU%yh;ehb ;;;  
When the aggravated vatha nadi combines with aggravated kabha 
nadi, there is genesis of meha disease in the body. In the  affected 
individuals body is emaciated thin and pale.  
‘ghh;j;jpL %d;Wk; gjpe;J nkype;J epw;fpy; 
Njh;e;jpL Nkfk; te;Njhd;wpNa nghUe;jp nka;apy;” 
        -jpU%yh; ehb;;;  
In madhumegam, three Naadis are feeble and weak.  
‘gw;gpbf;f Nkfk; vd;why; gpj;jkPWk; 
ghyfNd fhq;if nfhz;L ePuhk; ghNu” 
        -ghpg+uzehb 
Any alteration in vatha, pitha, kabha leads to meganeer disease.  
‘JuzKld; ePh;g;ghL nfh;g;gg; ghlhzhw; 
nrhy;YfpNwd; ehbnay;yhe;  fod;W fhZk;” 
        -ghpg+uzehb  
 ‘ePh;Nkfkhdth;f;F ehb jhDk; 
ePh;kakha; ehbnay;yhk; gyNk nfl;Lf; 
fhh;Nkfk; NghNyte; njhpNky; Guz;L  
tpOk;GOg; NghyNt Guz;L fhl;Lk;” 
        -ghpg+uzehb 
Sparisam (Palpation): 
 The following features can be found out by sparisam. Dryness of 
the skin, oedema, diabetic ulcer.  
Naa (tongue): 
In the examination of tongue its colour, coating, dryness, 
salaivation, deviation, movement, taste and the conditions of teeth and 
gums are also  to be noted.  
In mathumegam dryness of tongue due to excessive loss of water 
and electrolytes.  
Niram (Colour): 
The colour of the skin, nails, hair, conjunctiva, teeth and mucous 
membrane all are to be noted.  
Mozhi(speech): 
 Here the quality of the voice is assessed whether of nasal character, 
shrill, hoarseness, slurred inarticulated. Types of aphasia whether 
expressive or comprehensive dysphonia all are to be noted. 
Vizhi (Eye): 
 Both sensory and motor disturbance are noted.  In madhumegam 
visual disturbances (blurring of vision, glaucoma, cataract) may be 
present in some cases.  
Malam (faces): 
 In the examination of malam its nature whether it is solid, 
semisolid or liquid and its colour and quantity also be noted.  Other 
findings such as diarrhoea, constipation, presence of blood, mucous 
membrane, undigested food and odour all are to be noted.  
Moothiram (urine):- 
In the examination of urine , its colour, odour, quantity, presence of 
frothy, blood, pus, Inorganic sediments, abnormal constituents such as 
sugar, protein etc. And the frequency of micturitions are to be noted.  
Methods of urine examination:- 
 Neer kuri 
 Neikuri 
Collection of urine:- 
Prior to the day of urine examination the patient should be advised 
to take a balanced diet and rest. The first urine of the patient is collected 
in glass container. 
The colour of urine is noted and a drop of gingelly oil is added in 
to the container and the tendency of spread is noted with in 1 ½ hour. 
Though the urine should be examined only according to the rules 
and regulation, at time of emergency these can be relaxed. 
Neerkuri of Madhumegam is studied as follows:- 
1. Niram: 
Clear and white. This is due to kabha variation.  
2. Edai:          
Consistency of urine is just like honey.  
3. Manam:    
Just like a honey, ants and flies are attracted towards the voided 
urine.  
4. Nurai:  
At the time of urination, urine may have frothy appearance.  
5. Enjal:   
Large quantity of urine is passed. 
If the urine is lightly transparent it indicates the vitiation of kabha 
in which the prognosis is said to be very bad.  
‘ntz;ikAw;W kpfj; njspTilj;Njy; 
   cz;ikahe; Rj;j rPjsj; Jjfkhh; 
  ,e;ePh;g; grg;glhjpj;tDila Ae;juk;  
   Ke;ePh; ngUf;fkopthd; ca;jnthf;FNk”  
       -Njud;;;; 
‘Gz;zPh; Nkfg;Gz; fz;khg;gpzp 
ez;zpy; epj;jpa ehjpak; MnkDk; 
       -epj;jpa ehjPak;; P ;; P ;; P ; 
Neikuri: 
 A drop of gingelly oil is dropped in to a wide vessel containing the 
urine to be tested and kept it under the sunlight. The variations   of three 
thathus in disease can be diagnosed by the behavior of gingelly oil on the 
surface of urine. 
 ‘muntz ePz;bd; m‡Nj thjk;” 
The drop of oil spread like a snake, it indicates vatham.   
‘Mop Nghw; gutpd; m‡Nj gpj;jk;” 
 
if the drop of oil spread like a ring it indicates pitham.  
‘Kj;njhj;J epw;fpd; nkhoptjd; fgNk” 
If the drop of oil assumes a pearl shape, it is presumed to be kabha. 
By the careful examination of the urine with gingelly oil, the 
physicians can know whether the disease is curable or not. For this 
purpose siddhars explained various spreading tendencies of oil on urine 
surface of define prognosis of disease. 
Noi kanippu vivadham: (Differential diagnosis): 
1. Thelineeer: 
The signs and symptoms of the thelineer were polyuria (Voided 
urine is clear and snow like appearance), Polydipsia, loss of appetite, loss 
of body weight, and dryness of skin, constipation or diarrhoea, muscle 
cramps.  
Due to the presence of loss of appetite and absence of excessive 
sugar in blood and urine sample, this disease can differentiated from 
madhumegam.  
2. Due to prolonged intake of diuretics: 
 Due to the history of prolonged intake of diuretics the patient may 
have symptoms of polyuria. But due to the absence of excessive sugar in 
blood and urine sample the symptoms can be differentiated form 
madhumegam.  
Noi Nithanam (prognosis): 
 As per siddha system four types of mega formed as a result of 
vathaneer is incurable. The six types arising due to the vitiation of pitham 
could be cured with great difficulty.  
 But then ten types of pramegam arising due of iyyam are curable 
by proper treatment. 
 Maruthuvam: 
‘itj;jpa nray; itj;jpakhNk 
gythW khWjyile;J nfLf;fpd;w cliy epiyf;Fk;gb 
khWjy; mZfhkYk; xNu jd;ikahf 
nra;Jk; mjdhyhQ; nrapyf; Fiwtpd;wp 
elf;fr; nra;tJ njJNth mJNt itj;jpak;”  
        -jpU%yh; ;;; -800 
In siddha system of medicine is not only for treat the disease, but 
also prevent the disease and improve the immunity. This is said as 
follows. 
Kaapu - Prevention  
Neekkam - Treatment 
Niraivu - Restoration 
Line of treatment: 
 The derangement of thridosha especially the pithathathu is the 
mainfactor for madhumegam. This happens especially during once pitha 
period of life that is 33 to 66years of life. So Vamanam was given to the 
patients before treatments. 
1.trk;G FbePh;   - 30ml (fhiyapy; 2 my;yJ 3 Kiw ju the;jpahFk;)  
the;jpepw;fhtpby; nfhj;jky;yp FbePh; 30ml gUfTk;. 
Then the first day trial medicines were given. 
‘Nth;ghU jioghU kpQ;rpdf;fhy; nky;y nky;y  
gw;g nre;J}uk; ghNu” 
  -Fzghl jhJrPt tFg;G.P ;P ;P ;  
Hence the author tries the herbal preparation “Neerizhivu 
Chooranam” for antidiabetic activity.  
Diet in siddha system:- 
‘czNt kUe;J  kUe;Nj czT” 
-jpU%yH 
  
 
‘kUe;njd Ntz;lhthk; ahf;iff; mUe;jpaJ  
mw;wJ Nghw;wp Azpd;”  
- jpUf;Fws; ; ;; ;; ;  
Siddha system says a great importance on the observation of ruks 
regarding diet in everyday life because the siddha system has rightly  
realised that the basic factor of the body is food. That is Annamayakosam  
is the first among the five kosams constituting our physical and mental 
existence. To prevent the occurrence of the disease, elaborate inference 
regarding food item in our daily diet is given in the text book of siddha.  
Principles of Diet therapy: 
Diet should be balanced: 
It should have 10-15% calories from proteins, 20-25% calories 
from fats and rest of 60-65% from complex carbohydrates with adequate 
vitamins and minerals. 
Quantity of the diet: 
For under weight and normal weight diabetic there need not any 
restriction on calories. For an overweight diabetic, reduction in the 
number of calories is essential. Total Calories should be approximately 
30cal/kg of body weight + extra allowance of physical activity. 
Simple sugar need to be avoided: 
 Simple sugars like cane sugar, glucose, sweets, soft drinks, cakes, 
ice creams should be avoided in day diet as they are rapidly absorbed and 
cause sudden rise in the blood glucose.  
Fibre in plenty: 
 Diet should be rich in fibre, approximately 20-30gm / day. Grain 
foods should be consumed with their natural fibrous coating eg. whole 
wheat flour instead of refined brown bread instead of white fruits with 
peals, instead of fruit juices have been widely recommended for diabetics 
because of its fibre content.  
Fats: 
Total intake of fats should not exceed 25% of calories. Animal fats 
(Saturated) ingestion should be limited.  
Fats and cooking oils:- 
Fats and oils are essential components of human diet 20-25% of the 
total calories should come from them. In a 2000 calories diet, this amount 
to 40-50gm oil per day.  
Poly unsaturated fats are less atherogenic than monounsaturated 
and saturated fats. Daily cholesterol intake in diet should be less than 250 
mg.  
Essential fatty acids play an imporatant role in lipid physiology and 
protect against atheroscelerosis by lowering cholesterol levels and 
regulates the clotting mechanisms and maintaining  the stability of 
vascular endothelial cells.  
czT Kiwfs;:;;; - 
jhuhskhf Nrh;f;fNtz;ba czTfs;: 
fPiufs;   fhul; 
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Exercise: 
 Burn calories to earn them.  From a medical point of view such 
activities are most welcome as there is no doubt about the importance of 
exercise in promoting physical and mental health and perhaps even in 
preventing and helping to care disease.  
 During exercise, whole body oxygen consumption may increase by 
as much as 20 fold and even greater increase may occur in the working 
muscles.  
 To meet its energy needs under these circumstances,  Skeletal 
muscle uses, at a greatly increased rate its own stores of glycogen and 
triglycerides, as well as free fatty acids derived  from break   down of 
adipose tissues,  triglycerides and glucose released from liver. 
 The presence of high levels of insulin, due to exogenous insulin 
administration, can attenuate or even prevent the increased mobilization 
of glucose and other subtrates induced by exercise and hypoglycaemia 
may ensure.  
 Indeed, in patients with type 2 diabetes exercise may improve 
insulin sensitivity and assist in diminishing elevated blood glucose levels 
in to the normal ranges.  
Yogasana treatment for madhumegam : 
According to Thirumanthiramn Yoga is the attainment of spiritual, 
psychological and physical perfection. As the body is said to be the abode 
of divinity. Thirumoolar has advised each and every individual aspiring 
for self realisation should practice yogasanam. It is a science that helps to 
lead a pure and healthy life. The practice of yoga lessens and prevents the 
decay of issues by increasing with abundant energy. 
 Aasanaas are nothing but a kind of yogic exercises. There are 
innumerable types of Aasanaas.  
According to Thirumoolar, each yogasanam is indicated for a 
definite effect in a particular region of the system by stimulating the 
internal organs to function in a normal way and to co-ordinate bodily 
functions. 
The following aasanaas are advised for controlling madhu megam  
 Padmaasanam 
 Mayuraasanam 
 Chakkaraasanam 
 Pachimothaasanam 
 Vilaasanam 
 Mathsyaasanam 
 Pujangaasanam 
 Sarvaangaasanam 
All these aasanas should be practiced daily and regularly which can 
be of immense value to patients of madhumegam. All these aasanaas 
activate the pancreatic cells and have a curative value. These helps in 
retiring cellular function of the pancreas and activate them to work more.  
Out of these aasanas “Vilaasanam” and “Mayuraasanam” are 
specifically helps in the treatment of madhumegam.   
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DIABETES MELLITUS 
Definition: 
 Diabetes mellitus is a clinical syndrome characterized by 
hyperglycaemia due to absolute or relative deficiency of insulin.  
 Lack of insulin affects the metabolism of carbohydrate ,protein and 
fat and causes a singnificant disturbance of water and electrolyte 
homeostasis. 
Epidemiology: 
 Diabetes is worldwide in distribution and the incidence of both 
type 1 and type 2 diabetes is rising day by day.  It is estimated that, in the 
year 2000, 150 million people worldwide had diabetes, and this is 
expected to increasing double the amount by the year  2010. It is 
associated with several contributory factors including increased 
longevity, obesity, unsatisfactory diet, sedentary lifestyle and increasing 
urbanization.  
 However, the prevalence of both types of diabetes varies 
considerably around the world, and is related to differences in genetic and 
environmental factors. A pronounced rise in prevalence occurs in migrant 
populations to industrialized  countries, e.g. Asian and Afro-Carribbean 
immigrants to the United Kingdom.Many more cases of type 2 diabetes 
remain undetected. 
DM is expected to continue as a major health problem, because of 
its serious complications, especially  renal disease, ischemic heart 
disease, gangrene of the lower extremities and blindness in the adults. 
 Anatomy of the pancreas: 
Pancreas is a retro-peritoneal, fleshy organ, has both endo and 
exocrine function.  It is supra-umbilical, intrahepatic, posterio-abdominal, 
retroperitoneal organ, crossing the mid-line from right to the left.  As it’s 
retroperitoneal, the organ does  not move with respiration.   
 Generally, it has head, neck, body and tail.  The head of the 
pancreas is within the concavity of the deodenum.  The neck crosses the 
portal vein.  The body crosses the great vessels of the abdomen like, 
inferior vena cava, aorta, and left renal blood vessels.  The tail of the 
pancreas is in the left hypochondrium and, it contacts the hilum of the 
spleen.  The superior border is related to spleenic artery.  The anterior 
border gives attachment to transverse mesocolon.   
Histophysiologically, this is a compound tubular gland showing 
endo and exocrine functions of which are correlated with pituitary gland. 
Microscopic anatomy of islets of – langerhans: 
         They are found more in the tail of the pancreas than in the other 
parts. They form about 1 – 2% of pancreatic weight.  The histological 
structure of the islets shows Alpha, Beta and Delta cells, of which, 
 Alpha cells form 20% and glucagon secreting 
 Beta cells form about 75% and insulin secreting 
 Delta cells form about 5% and gastrin secreting. 
           Beta cells are the source of insulin hormone.  The cells are 
polyhydral, the nuclei are centrally or eccentrically placed, the cytoplasm 
is grannular, filled with prominent secretary vacuoles containing few 
ribosomes.  The secretory granules show species variations.  In man they 
are spherical or elongated crystalline body.   
 Insulin Biosynthesis, Secretion, and Action:  
Biosynthesis: 
 Insulin is produced in the beta cells of the pancreatic islets. It is 
initially synthesized as a single-chain 86-amino-acid precursor 
polypeptide, namely preproinsulin. By the action of proteolysis the 
aminoterminal single peptide is removed and  giving rise to proinsulin. 
Proinsulin is structurally related to insulin-like growth factors I and II, 
which bind weakly to the insulin receptor. Cleavage of an internal 31-
residue fragment from proinsulin generates the C peptide and the A (21 
amino acids) and B (30 amino acids) chains of insulin, which are 
connected by disulphide bonds.  
        The mature insulin molecule and C peptide are stored together and 
cosecreted from secretory granules in the beta cells. Because the C 
peptide is less susceptible than insulin to hepatic degradation, it is a 
useful marker of insulin secretion and allows discrimination of 
endogenous and exogenous sources of insulin in the evaluation of 
hypoglycemia. 
Secretion: 
       Glucose is the key regulator of insulin secretion by the pancreatic 
beta cell, although amino acids, ketones, various nutrients, 
gastrointestinal peptides, and neurotransmitters also influence the insulin 
secretion. Glucose levels >3.9 mmol/L (70 mg/dL) stimulate insulin 
synthesis, primarily by enhancing protein translation and processing, as 
well as inducing insulin secretion. Glucose stimulates insulin secretion 
through a series of regulatory steps that begin with transport into the beta 
cell by the GLUT2 glucose transporter. Glucose phosphorylation by 
glucokinase is the rate-limiting step that controls glucose-regulated 
insulin secretion. 
 Metabolic Actions of Insulin: 
Anabolic actions: 
a. Carbohydrate metabolism: 
 Insulin increases  the glucose transport (muscle, adipose tissue),  
phosphorylation, glycogenesis , glycolysis, pyruvate dehydrogenase 
activity and pentose phosphate shunt. 
b. Lipid metabolism: 
 Insulin increases the triglyceride synthesis , fatty acid synthesis 
(liver) and lipoprotein lipase activity (adipose tissue). 
c. Protein metabolism: 
 Insulin increases the amino acid transport and protein  synthesis. 
Anticatabolic actions: 
a. Carbohydrate metabolism: 
 Insulin decreases the gluconeogenesis and glycogenolysis. 
b. Lipid metabolism: 
 Insulin decreases the lipolysis,  ketogenesis and fatty acid 
oxidation (liver). 
c. Protein metabolism: 
        Insulin decreases protein degradation. 
Normal Blood Sugar Level: 
         In normal persons, blood glucose level is controlled within a narrow 
range.  After the overnight fasting, in early morning, the blood glucose 
level ranges between 80 and 90 mg/dl of blood.  Between first and second 
hour after meals (post prandial), the blood glucose level raises to 120-140 
mg/dl. The glucose level in the blood is brought back to normal at the end 
of second hour after the meals. 
 Necessity Of Regulation Of Blood Glucose Level: 
        Regulation of blood glucose level is very essential because, glucose 
is the only nutrient that can be utilized by tissues of brain, retina and 
germinal epithelium of the gonads. 
Role Of Liver In The Maintenance Of Blood Sugar Level: 
        Liver acts as an important glucose buffer system.  When blood 
glucose level increases after a meal, the excess glucose is converted into 
glycogen and stored in liver. When the blood glucose level falls, from the 
normal range the liver glycogen is converted into glucose and released 
into the blood from the liver cells. 
Role of Insulin In The Maintenance Of Blood Sugar Level: 
Insulin is the only  antidiabetic hormone, as it reduces blood sugar 
level.  It reduces the blood sugar level by the following actions. 
1. Transport and uptake of Glucose: 
When a food with excess amount of carbohydrate is taken, the 
blood sugar level is increased.  Immediately, pancreas secretes insulin.  
The insulin facilitates the transport of glucose from the blood into the 
cells by increasing the permeability of cell membrane to glucose.   
Insulin enhances the uptake of glucose by all the tissues 
particularly by liver, muscle and adipose tissues.  However, insulin is not 
required for glucose uptake in some tissues like brain (except 
hypothalamus), renal tubules, mucus membrane of intestine and red blood 
cells. 
2. Peripheral utilization of Glucose: 
The glucose entering the cells is oxidized by most of the cells 
immediately.  The rate of utilization depends upon intake of glucose, and 
the glucose utilization is enhanced by insulin. 
 3. Storage of Glucose: 
Insulin promotes the rapid conversion of glucose into glycogen 
(glycogenesis) in muscle and liver.  Thus, glucose is stored in these two 
organs in the form of glycogen.  The insulin causes conversion of glucose 
into fatty acids. 
4. Inhibition of Glycogenolysis: 
Insulin prevents the breakdown of glycogen into glucose in 
muscles and liver. 
5. Inhibition of Gluconeogenesis: 
Insulin prevents gluconeogenesis i.e., it prevents the formation of 
glucose from proteins by following ways: 
        a) Inhibiting the release of amino acids from muscle and 
         b) Inhibiting  the activities of enzymes involved in gluconeogenesis. 
Thus insulin decreases the blood sugar level in following manner: 
 Facilitating the transport and uptake of glucose by the cells. 
 Increasing the peripheral utilization of glucose. 
 Conversion of glucose into glycogen in liver and muscle. 
 Prevention of glycogenolysis. 
 Inhibition of gluconeogenesis. 
Role Of Glucagon In The Maintenance Of Blood Sugar Level 
1. Glucagon increases glycogenolysis (breakdown of glycogen into 
glucose) in liver.  And, the glucose thus formed is released from the 
liver cells into the blood.  Glucagon does not induce glycogenolysis in 
muscle.  
2. Glucagon increases gluconeogenesis (formation of glucose from 
proteins) in liver. 
 Role Of Other Hormones In The Maintenance Of Blood Sugar Level 
I.Growth Hormone 
        Growth hormone increases the blood sugar level by the following 
ways: 
 Decrease in the peripheral utilization of glucose for the production 
of energy. 
 Increase in the deposition of glycogen in the cells. 
 Decrease in the uptake of glucose by the cells. 
 Diabetogenic effect of growth hormone. 
II.Cortisol 
Cortisol increases the blood glucose level by acting on liver cells 
and the peripheral tissues.  Following are the actions of cortisol on 
glucose metabolism. 
a. It increases the gluconeogenesis in liver from amino acids. When 
the amino acids enter the liver, gluconeogenesis is accelerated. 
b. It decreases the glucose (anti-insulin action) uptake by peripheral 
cells and the utilization of glucose. 
III. Adrenaline 
    Adrenaline increases the blood glucose level  by increasing 
glycogenolysis in liver and muscle.  So, a large quantity of glucose enters 
the blood. 
IV. Thyroxine 
Thyroxine increases the blood sugar level by the following ways; 
 It increases the absorption of glucose from gastrointestinal tract. 
 It increases the breakdown of glycogen into glucose. 
 It accelerates the process of gluconeogenesis. 
 Classification 
Etiologic Classification of Diabetes Mellitus  
I. Type 1 diabetes – 10%  (β-cell destruction, usually leading to absolute 
insulin deficiency) 
 A. Immune-mediated 
 B. Idiopathic.  
II. Type 2 diabetes – 80% (may range from predominantly insulin 
resistance with relative insulin deficiency to a predominantly insulin 
secretory defect with insulin resistance) 
III. Other specific types of diabetes – 10% 
A. Genetic defects of – β cell function characterized by mutations in 
various enzymes: 
1. Hepatocyte nuclear transcription factor (HNF) 4 (MODY 1) 
2. Glucokinase (MODY 2) 
3. HNF – 1 (MODY- 3)  
4. Insulin promoter factor (IPF) 1 (MODY 4)  
5. HNF – 1 (MODY 5) 
6. Mitochondrial DNA  
7. Proinsulin or Insulin conversion. 
B. Genetic defects in insulin action 
C. Diseases of the exocrine pancreas-pancreatitis,  neoplasia, cystic 
fibrosis, hemochromatosis, fibrocalculous pancreatopathy. 
D. Endocrinopathies like acromegaly, Cushing’s syndrome,  
pheochromocytoma, hyperthyroidism, aldosteronoma 
E. Drug- or chemical-induced Vacor, pentamidine, nicotinic acid, 
glucocorticoids, thyroid hormone, diazoxide, adrenergic 
agonists,thiazides, phenytoin, interferon, protease inhibitors, 
clozapine, beta blockers. 
F. Infections: congenital rubella, cytomegalovirus 
G. Uncommon forms of immune-mediated diabetes: “stiff-man” 
syndrome, anti-insulin receptor antibodies 
H. Other genetic syndromes sometimes associated with diabetes: Down’s 
syndrome, Klinefelter’s syndrome, Turner’s syndrome, Friedreich’s 
ataxia, Huntington’s chorea, Laurence-Moon-Biedl syndrome, 
myotonic dystrophy, porphyria,  Prader-Willi syndrome 
IV. Gestational diabetes mellitus (GDM): 
Gestational diabetes, defined as hyperglycaemia diagnosed for the 
first time in pregnancy. About 4% pregnant women develop DM due to 
metabolic changes during pregnancy.  Although they reverse back to 
normal glycaemia after delivery.  These women are prone to develop DM 
later in their life.   
 TYPE 1 DIABETES 
(INSULIN DEPENDENT DIABETES MELLITUS)  
Pathogenesis 
Genetic Considerations  
The  genetic  contributions  to  type  1  DM  involve  multiple  
genes.  The development of the disease appears to require inheritance of a 
sufficient complement of genes to confer susceptibility to the disorder.  
The major susceptibility gene for type 1 DM is located in the HLA 
region on chromosome 6. Polymorphisms in the HLA complex appear to 
account for 40 to 50% of the genetic risk of developing type 1 DM.  
Environmental Factors  
It has been proposed that lack of exposure to pathogenic organisms 
in early childhood limits maturation of the immune system and increases 
susceptibility to autoimmune disease (‘the hygiene hypothesis’).  
1 Viruses  
2.Diet  
3.Stress  
4.Immunological factors  
Viruses  
The  evidence  that  viral  infection  might  cause  some  forms  of  
type  1 diabetes is derived from studies where virus particles known to 
cause cytopathic or autoimmune damage to beta cells. The viruses have 
been isolated from the pancreas.  
Virusus that causes type 1 diabetes include  
Mumps,Coxsackie B4, retroviruses, rubella  (in utero), 
cytomegalovirus and Epstein-Barr virus.  
 Diet:  
Dietary factors may influence the development of type 1 diabetes.   
Bovine  serum  albumin  (BSA),  a  major  constituent  of  cow’s  milk,  
has  been  implicated  in  triggering type 1 diabetes. It has been shown 
that children who are given cow’s milk early  in infancy are more likely 
to develop type 1 diabetes than those who are breastfed.   BSA  
may cross the neonatal gut and raise antibodies which, because of the 
close homology  between BSA,  the Beta chain of HLA class II antigens 
and a heat-shock protein expressed  by beta cells, could cross-react with 
and cause damage to beta cell components. Various nitrosamines  and 
coffee have been proposed as potentially diabetogenic factors.  
Stress:  
Stress may progress the development of type 1 diabetes by 
stimulating the  secretion of counter-regulatory hormones and possibly by 
modulating immune activity.  
Immunological Factors  
Type 1 diabetes is a slow T cell-mediated autoimmune disease.   
Family  studies have produced  evidence that destruction of the insulin-
secreting cells in the  pancreatic islets takes place over many years.    
Hyperglycaemia accompanied by the  classical  symptoms  of  diabetes  
occurs  only  when 70-90%  of  beta  cells  have  been  destroyed.  
 TYPE 2 DM 
( NON INSULIN DEPENDENT DIABETES MELLITUS) 
Type  2 DM is a heterogeneous disorder with a complex etiology 
that develops in response to genetic and environmental influences. 
Central to the development of type 2 DM are insulin resistance and 
abnormal insulin secretion. Although controversy remains  regarding  the  
primary  defect,  most  studies  support  the  view  that  insulin resistance 
precedes insulin secretory defects.  
Risk factors for Type 2 Diabetes Mellitus  
1. Family history of diabetes (i.e., parent or sibling with type 2 
diabetes) 
2. Obesity (i.e., ‘>20% desired body weight or BMI> 27 kg/m2) Age > 
45 years. 
3. Race/ethnicity(e.g.   African   American,   Hispanic   American,   
Native American, Asian American, Pacific Islander) 
4. Previously identified IFG or IGT. 
5. History of GDM or delivery of baby over 9 Ibs. 
6. Hypertension (blood pressure> 140/90 mmHg) 
7. HDL cholesterol level<0.90 mmol/L  (35 mg/dL) and/ or a 
triglyceride level>2.82 mmol/L(250 mg/dL) 
8. Polycystic ovary syndrome. 
Genetic Considerations  
Type 2 DM has a strong genetic component. Although the major 
genes that predispose to this disorder have yet to be identified, it is clear 
that the disease is polygenic and multifactorial.  Various genetic loci 
contribute to susceptibility, and environmental factors (such as nutrition 
and physical activity) further modulate phenotypic expression of the 
disease. The concordance of type  2 DM in identical twins is between  70 
and  90%. Individuals with a parent with type 2 DM have an increased 
risk of diabetes; if both parents have type  2 DM, the risk in offspring 
may reach  40%. Insulin resistance, as demonstrated  by  reduced  glucose  
utilization  in  skeletal  muscle,  is  present  in  many nondiabetic, first-
degree relatives of individuals with type 2 DM. However, definition of 
the genetic abnormalities of type 2 DM remains a challenge because the 
genetic defect in insulin secretion or action may not manifest itself unless 
an environmental event or another genetic defect, such as obesity, is 
superimposed.  
Environmental Factors  
 Lifestyle  
 Malnutrition in utero  
 Age  
 Pregnancy  
1. Life Style  
Epidemiological  studies  of     type  2  diabetes  shows that   
overeating, especially when combined with obesity, middle-aged people 
with diabetes eat significantly more and are fatter and less active than 
their non-diabetic siblings. Obesity probably acts as a diabetogenic factor 
(through increasing resistance to   the action of insulin) in those 
genetically predisposed to develop type 2 diabetes.  
2. Malnutrition In Utero  
Retrospective  analysis  of  the  birth  weight  of  males  born  an  
inverse relationship between weight at birth and at 1 year, and the 
development of type 2 diabetes in late adulthood.  
It  is  proposed  (but  not  yet  proven)  that  malnutrition  in  
utero  may  programme  beta  cell  development  and  metabolic  
functions  at  a  critical  period,  so predisposing to type 2 diabetes later in 
life. Smoking during pregnancy has also been implicated.  
3. Age  
Age is an important risk factor for type 2 diabetes. Over 70% of all 
cases of diabetes occur after the age of 50 years.   Type 2 diabetes is 
principally a disease of the middle aged and elderly, affecting 10% of the 
population over the age of 65.  
4. Pregnancy  
During normal pregnancy, insulin sensitivity is reduced through the 
action of placental hormones and this affects glucose tolerance. The term 
‘gestational diabetes’ refers  to  hyperglycaemia  occuring  for  the  first  
time  during  pregnancy. Repeated pregnancy may increase the likelihood 
of developing irreversible diabetes, particularly in obese women; 80% of 
women with gestational diabetes ultimately develop permanent clinical 
diabetes requiring treatment.  
Pathogenesis of type 2 diabetes  
Insulin resistance  
Increased hepatic production of glucose and resistance to the action 
of insulin in muscle  are invariable in both obese and non-obese patients 
with type2 diabetes. Insulin resistance may be due to any one of three 
general causes: an abnormal insulin molecule, an excessive amount of 
circulating antagonists, or target tissue defects. The last is the most 
common cause of insulin resistance in type 2 diabetes and seems to be the 
predominant abnormality in those with more severe hyperglycaemia.  
A characteristic feature of type 2 diabetes is that it is often associated 
with other medical disorders including obesity, hypertension and 
hyperlipidaemia.  It has been suggested that this cluster of conditions, all 
of which predispose to cardiovascular disease, is a specific entity ( the 
‘insulin resistance syndrome’ or ‘metabolic syndrome’ ), with insulin 
resistance being the primary defect.  
The features of insulin resistance syndrome are Hyperinsulinaemia, 
type 2 DM  or  impaired  glucose  tolerance,  hypertension,  Low  HDL  
cholesterol, Elevated triglycerides, central(visceral) obesity, 
microalbuminuria,  increased fibrinogen, increased plasminogen activator 
inhibitor-1and elevated plasma uric acid.  
Pancreatic beta cell failure  
In type 2 diabetes there is only moderate reduction in the total mass 
of  pancreatic  islet  tissue  which  is  consistent  with  a  measurable  fall  
in  plasma  insulin  concentration  when  related  to  the  blood  glucose 
level.  However, some pathological changes are typical of type  2 
diabetes, the most consistent of which is deposition of  
amyloid. This is accompanied by atrophy of the normal tissue, 
particularly islet epithelial cells.  Islet  amyloid  is  composed  of  
insoluble  fibrils  formed  from  islet  amyloid polypeptide (also known as 
amylin). Small quantities of islet amyloid are very common in elderly 
non-diabetic patients, and the role of islet amyloid in the pathogenesis of 
type 2  diabetes is uncertain. Deposition of amyloid is probably not a 
cause of diabetes but rather reflects a pathological process which is 
increased in type 2 diabetes.  
MODY GENETICALLY   DEFINED, MONOGENIC   FORMS   OF   
DIABETES MELLITUS  
MODY comprises a phenotypically and genetically heterogeneous 
subtype of DM. Onset of the disease typically occurs between the ages of  
10 and  25. Five different varities of MODY, 
MODY1, MODY2, MODY3, MODY4, MODY5.  
MODY2  the  most  common  variant,  is  caused  by  mutations  in  
the  glucokinase gene. As a result of glucokinase mutations, higher 
glucose levels are required  to elicit insulin secretory responses, thus 
altering the set point for insulin secretion.  
GESTATIONAL DIABETES:  
Gestational diabetes, defined as hyperglycaemia diagnosed for the 
first  time in pregnancy, is a common problem.   It occurs in individuals 
who have an inherited  predisposition to develop diabetes and may take 
the form of either type I or type II diabetes.   The hyperglycaemia may 
not disappear after delivery.   It is associated not only with increased rates 
of perinatal mortality and neonatal morbidity but also with a high 
incidence  (possibly as  great as 80%  at  25  years postpartum) of 
subsequent clinical diabetes (both type I and type II) in the mother. 
Normalisation of metabolism, whether by treatment with dietary 
measures alone or, more commonly, with additional treatment in the form 
of insulin, undoubtedly reduces the fetal risk; its effect on diminishing the 
maternal risk of subsequent diabetes is less certain.  
The clinical features of the two main types of diabetes are 
compared below. Comparative Clinical Features of Type 1 And Type 2 
Diabetes  
The classical symptoms of thirst, polyuria, nocturia and rapid   
weight loss are prominent in type 1 diabetes, many of whom are 
asymptomatic or have non-specific complaints such as chronic fatigue 
and malaise.  
Uncontrolled diabetes is associated with an increased    
suspectibility to infection and patients may present with skin sepsis(boils) 
and genital candidiasis and complain of pruritus vulvae and balanitis.  
Patients with type 1 diabetes often have no physical signs 
attributable to diabetes, but weight loss is common. The physical signs in 
patients with type 2 diabetes at diagnosis depend on the  mode  of  
presentation.  More  than 70%  are  overweight,  and  obesity  may  be 
central(truncal or abdominal). Obesity is less common in developing 
countries.  
Hypertension is present in 50% of patients with type 2 diabetes. 
Although hyperlipidaemia  is  also  common,  skin  lesions  such  as  
xanthelasma  and  eruptive xanthomata are relatively rare.  
MAJOR  MANIFESTATIONS  OF  DISEASE  
Hyper Glycaemia:  
Hyperglycaemia  is  a  very  common  biochemical  abnormality.  It  
is frequently detected on routine biochemical analysis of asymptomatic 
patients, and is found  during  conditions  which  impose  a  burden  on  
pancreatic  beta  cells,  such  as pregnancy,  severe  illness  or  treatment  
with  drugs  such  as  corticosteriods(‘stress hyperglycaemia’).  
Pathogenesis: 
Depending upon etiology of DM, hyperglycaemia may result from:  
Reduced insulin secretion;  
Decreased glucose use by the body; and  
Increased glucose production.  
Symptoms Of Hyperglycaemia Associated With Diabetes  
 Thirst, dry mouth.  
 Poly uria.  
 Nocturia.  
 Tiredness, fatigue, irritability.  
 Recent change in weight.  
 Blurred vision.  
 Pruritus vulvae, balanitis(genital condidiasis)  
 Nausea; headache, hyperphagia; predilection for sweet foods.  
Diabetic Ketoacidosis:  
Keto acidosis is caused by insulin deficiency and an increase in 
catabolic hormones, leading to hepatic over-production of glucose and 
ketone bodies.  
 
The cardinal biochemical features of diabetic ketoacidosis are:  
 Hyperglycaemia 
 Hyperketonaemia  
 Metabolic acidosis  
Investigations:  
The  following  are  important  but  should  not  delay  the  
institution  of intravenous fluid and insulin replacement:  
 Urea and electrolytes, 
 blood glucose  
 Arterial blood gases to assess the severity of acidosis  
 Urine analysis for ketones  
 Full blood count  
 Infection screen: blood and urine culture, chest radiograph.  
Hypoglycaemia  
Hypoglycaemia  (i.e.  a  blood  glucose<3.5  mmol/l)  is  a  result  
of  the treatment of diabetes rather than a manifestation of the disease 
itself. It occurs often in those  taking  a  sulphonylurea  drug.  Most  
patients  recognize  the  symptoms  of  hypoglycaemia and can take 
appropriate remedial action; others are less aware of these and, if action is 
not taken, neuroglycopenia and reduced consciousness ensue.  
Causes of Hypoglycaemia:  
Errors   in   oral   hypoglycaemic   agent   or   insulin   dose/   
schedule/ administration Poorly designed insulin regimen, particularly if 
predisposing to nocturnal hyperinsulinaemia.  
 Missed, delayed or inadequate meal  
 Unexpected or unusual exercise 
 Alcohol  
 Lipohypertrophy  
 Gastroparesis due to autonomic neuropathy  
 Malabsorption, e.g. celiac disease  
 Unrecognised other endocrine disorder, e.g. Addison’s disease  
Common Symptoms of Hypoglycaemia  
a. Autonomic  
The common autonomic symptoms  of  hypoglycaemia  are    
sweating, trembling, hunger, pounding heart, and anxiety.  
b. Neuroglycopenic  
The common neuroglycopenic symptoms of hypoglycaemia are 
confusion, drowsiness, speech difficulty , inability to concentrate and 
incordination.  
c. Non-Specific  
The  common  non-specific  symptoms  of  hypoglycaemia  are  
nausea, tiredness and headache.  
DIAGNOSIS  
Revised criteria for diagnosing DM have been issued by consensus 
panels of experts from the National Diabetes Data Group and the World 
Health Organization  
Criteria for the Diagnosis of Diabetes Mellitus  
The revised criteria for the diagnosis of DM emphasize the FPG 
(fasting plasma  glucose)  as  the  most  reliable  and  convenient  test  for  
diagnosing  DM  in  asymptomatic individuals. A random plasma glucose 
concentration >11.1 mmol/L (200 mg/dL) accompanied by classic 
symptoms of DM (polyuria, polydipsia, weight loss) is  
sufficient for the diagnosis of DM. Oral glucose tolerance testing, 
although still a valid mechanism for diagnosing DM, is not recommended 
as part of routine screening.  
Glycated Haemoglobin: HBA1C  
Glycated  haemoglobin  provides  an  accurate  and  objective  
measure of  glycaemic control over a period of weeks to months. This can 
be utilized as an assessment  of glycaemic control in a patient   with 
known diabetes, but is not sufficiently sensitive to  
make a diagnosis of diabetes and is usually normal in patients with 
impaired glucose tolerance.  
Urine testing  
a. Glucose  
Testing the urine for glucose is the usual procedure for detecting 
diabetes, using sensitive glucose-specific dipstick methods. If possible, 
testing should be performed on urine passed 1-2hours after a meal since 
this will detect more cases of diabetes than a fasting specimen.  
Glycosuria always warrants full assessment.  
The greatest disadvantage of using urinary glucose as a diagnostic 
or screening procedure is the individual variation in renal threshold.   
Apart from diabetes, the most common cause of glycosuria is a low renal 
threshold for glucose, which is common  during  pregnancy  and  in  
young  people,  and  is  a  more  frequent  cause  of glycosuria than 
diabetes.  
b.Ketones  
c.Protein  
d.Blood Lipids  
 LABORATORY EVALUATION 
If the patient is a known diabetic, the following tests are to be advised  
 Fasting blood sugar (FBS)  
 Postprandial blood sugar (PPBS)  
 Glycated haemoglobin (HbA1c)  
 Blood urea  
 Serum creatinine  
 Urine protein  
 Haemogram  
 Complete Urine Examination 
 Lipids (total cholesterol, triglycerides, HDL, LDL)    
 Liver function tests (LFT)  
If the patient is not a known diabetic, the following tests can be 
advised  
 Glucose tolerance test (GTT)  
 Glycated haemoglobin (HbA1c)  
 Blood urea  
 Serum creatinine  
 Urine P/C ratio  
 Complete  urine examination  
 Lipids (total cholesterol, triglycerides, HDL, LDL)       
 Liver function tests (LFT) 
  ECG  
COMPLICATIONS:  
COMPLICATIONS OF DIABETES MELLITUS  
1. Acute Complications  
 Diabetic ketoacidosis (DKA)  
 Nonketotic hyperosmolar state(NKHS)  
 Hyper osmolar coma hypoglycemia  
CHRONIC COMPLICATIONS  
  Chronic  Complications  of  diabetes  are  due  to  Vascular  
damage  from  persistent hyperglycemia. Vascular damage leads to end-
organ damage. Other conditions associated  with diabetes, such as 
hypertension, dyslipidemia (as well as smoking) accelerate the  
development of vascular damage and the chronic complications of 
diabetes, which are the following:  
Diabetic Ketoacidosis:  
  Diabetic ketoacidosis is a major medical emergency and remains a 
serious cause of morbidity, principally in people with type 1 diabetes. 
The average mortality in developed countries is 5-10% and is higher in 
the elderly.  
  A clear understanding of the biochemical basis and 
pathophysiology of this problem is essential for its efficient treatment.  
Ketoacidosis is caused by insulin deficiency and an increase in catabolic 
hormones, leading to hepatic over-production of glucose and ketone 
bodies.  
The cardinal biochemical features of diabetic ketoacidosis are:  
 hyperglycaemia 
 hyperketonaemia 
 metabolic acidosis. 
 Hyperglycaemia causes a profound osmotic diuresis leading to 
dehydration and electrolyte loss, particularly of sodium and potassium. 
The metabolic acidosis forces hydrogen ions into cells, displacing 
potassium ions, which may be lost in urine or through  
vomiting.  
About half the deficit of total body water is derived from the 
intracellular compartment  and  occurs  comparatively  early  in  the  
development  of  acidosis  with relatively few  clinical  features;  the  
remainder  represents  loss  of extra  cellular  fluid sustained largely in the 
later stages. It is at this time that marked contraction of the size of the 
extra cellular space occurs, with haemo concentration, a decreased blood 
volume, and finally a fall in blood pressure with associated renal 
ischaemia and oliguria.  
Every  patient  in  diabetic  ketoacidosis  is  potassium-depleted,  
but  the plasma concentration of potassium gives very little indication of 
the total body deficit. Plasma potassium may even be raised initially due 
to disproportionate loss of water and catabolism of protein and glycogen.  
However,  soon  after  insulin  treatment  is  started  there  is  likely 
to  be precipitous fall in the plasma potassium due to dilution of extra 
cellular potassium byadministration of intravenous fluids, the movement 
of potassium into cells as a result of treatment with insulin, and the 
continuing renal loss of potassium.  
The severity of ketoacidosis can be assessed rapidly by measuring 
the plasma bicarbonate; less than 12 mmol/l indicates severe acidosis.  
Clinical features:  
Symptoms : Nausea, vomiting Thirst, polyuria, Abdominal  pain, 
Altered mental function and Shortness of breath 
Physical findings : Tachycardia, Dry mucous membranes, reduced 
skin turgor, Dehydration, hypotension, Tachypnea,   Kussmaul   
respirations, respiratory distress, Abdominal   tenderness, (may   resemble   
acute   pancreatitis   or   surgical abdomen) FeverLethargy, cerebral 
edema and possibly coma.  
Precipitating  events  Inadequate  insulin  administration,  infection  
(pneumonia/UTI/gastroenteritis/sepsis),   Infarction (cerebral,   coronary,   
mesenteric, peripheral) and drugs (cocaine)  
 Nonketotic Hyperosmolar State  
Clinical Features:   NKHS is most commonly seen in elderly 
individuals with type 2 DM. Its most prominent features include polyuria; 
orthostatic hypotension; and  a  variety  of  neurologic  symptoms  that  
include  altered  mental  status,  lethargy, obtundation, seizure, and 
possibly coma.  
The prototypical patient is a mildly diabetic, elderly individual 
with a several week history of polyuria, weight loss, and diminished oral 
intake that culminates in mental confusion, lethargy,  or coma. The 
physical examination reflects profound dehydration  and  hyperosmolality  
and  reveals  hypotension,  tachycardia,  and  altered mental status.  
NKHS  is  often  precipitated  by  a  serious,  concurrent  illness  
such  as myocardial infarction or stroke. Sepsis, pneumonia, and other 
serious  infections are frequent  precipitants  and  should  be  sought 
thoroughly.  In  addition,  a  debilitating condition (prior stroke or 
dementia) or social situation that compromises water intake may 
contribute to the development of the disorder. Finally, the development of 
NKHS can be associated with the use of certain medications (thiazide 
diuretics, glucocorticoids, phenytoin).  
2. Chronic Complications of Diabetes Mellitus  
a. Microvascular:  
 Eye disease  
 Retinopathy(nonproliferative/proliferative) Macular edema  
 Cataracts  
 Glaucoma  
 Sensory and motor neuropathy (mono- and polyneuropathy)  
 Autonomic Nephropathy.  
 b. Macrovascular:  
 Coronary artery disease  
 Peripheral vascular disease  
 Cerebrovascular disease  
c. Other:  
 Gastrointestinal (gastroparesis, diarrhoea)  
 Genito urinary (uropathy/sexual dysfunction) Dermatologic  
DIABETIC RETINOPATHY 
Diabetic retinopathy is the most common cause of blindness in 
adults between 30 and 65 years of age in developed countries.  
Pathogenesis:  
Hyperglycaemia  increases  retinal  blood  flow  and  metabolism  
and  has direct effects on retinal endothelial cells and pericytes, loss of 
which impairs vascular autoregulation. This  results   uncontrolled blood 
flow increases production of vasoactive  substances and endothelial cell 
proliferation, resulting in capillary closure. This causes  chronic retinal 
hypoxia and stimulated production of growth factors, including vascular  
endothelial  growth  factor (VEGF).  VEGF  acts  via  proteinkinase    C  
to  stimulate  endothelial  cell  growth (causing new  vessel formation)  
and  increased  vascular  permeability (causing exudative damage).  
Clinical Features Of Diabetic Retinopathy:  
 Microaneurysms 
 Retinal haemorrhages 
 Exudates 
 Cotton wool spots 
 Venous changes 
 Neovascularisation 
 Pre-retinal haemorrhage 
 Vitreous haemorrhage 
 Fibrosis 
INTRARETINAL MICROVASCULAR ABNORMALITIES  
Intraretinal  microvascular  abnormalities (IRMA)  are  dilated,  
tortuous capillaries which represent the remaining patent capillaries in an 
area where most have been occluded. 
Neovascularisation:  
This may arise from the venous circulation on the optic disc or the 
retina in response to areas of ischaemic retina. retinal detachment can 
occur due to contraction of adhesions between the vitreous and the retina.  
Venous Changes:  
These include venous dilatation  (an early feature probably 
representing increased  blood  flow), ‘beading’ (sausage-like  changes  
in  calibre)  and  increased tortuosity including ‘oxbow lakes’ or loops. 
These latter changes indicate widespread capillary non-perfusion 
and are a feature of advanced pre-proliferative retinopathy.  
Cataract:  
Cataract is a permanent lens opacity and is the most common cause 
of visual deterioration in the elderly population.  
The lens thickens and opacifies with age, and the increased 
metabolic insult to the lens in people with diabetes causes these changes 
to accelerate and occur prematurely. Very rarely, a type of cataract 
specific to diabetes occurs in young patients with poorly controlled 
diabetes, called a  ‘snow-flake’ cataract. This does not usually affect 
vision but tens to make fundal examination difficult.  
Renal Complications of Diabetes Mellitus:  
The nephropathy that develops in type 2 DM differs from that of 
type 1 DM in the following respects 
 microalbuminuria or over nephropathy may be present when type 2 
DM is diagnosed, reflecting its long asymptomatic period; 
  hypertension more commonly accompanies microalbuminuria or 
overt nephropathy in type 2 DM; and  
 microalbuminuria may be less predictive of progression to overt 
nephropathy in type 2 DM. Finally, it should be noted that 
albuminuria in type 2 DM may be secondary to factors unrelated to 
DM, such as hypertension, congestive heart failure, prostate disease, 
or infection.  
  Other renal problems may also occur in individuals with DM. Type 
IV renal tubular acidosis  (hyporeninemic hypoaldosteronism) occurs in 
many individuals with DM. 
NEUROPATHY AND DIABETES MELLITUS  
  Diabetic neuropathy occurs in approximately  50% of individuals 
with long-standing  type 1   and  type 2   DM.  It  may  manifest  as  
polyneuropathy, mononeuropathy, and/or autonomic neuropathy. 
a. Polyneuropathy/Mononeuropathy:  
  The  most  common  form  of  diabetic  neuropathy  is  distal  
symmetric polyneuropathy.  It  most  frequently  presents  with  distal  
sensory loss.  Hyperesthesia, parathesia, and pain also occur. Any 
combination of these symptoms may develop as neuropathy progresses. 
Physical examination reveals sensory loss, loss of ankle reflexes, and 
abnormal position sense.  
b. Diabetic polyradiculopathy  
c.Mononeuropathy (dysfunction of isolated cranial or peripheral nerves)  
d. Autonomic Neuropathy  
Cardiovascular Morbidity and Mortality:  
Cardiovascular disease is increased in individuals with type 1 or 
type 2 DM. The Framingham Heart Study revealed a marked increase in 
several cardiovascular diseases in DM including peripheral vascular 
disease, congestive heart failure, coronary artery disease,  myocardial  
infarction,  and  sudden  death (risk  increase  from  one-  to fivefold).  
The extremely high frequency of underlying cardiovascular disease 
in individuals with diabetes (especially in type 2 DM).The absence of 
chest pain (“silent ischemia”) is common in individuals with diabetes.  
Hypertension:  
  Hypertension  can  accelerate  other  complications  of  DM,  
particularly cardiovascular disease and nephropathy. Hypertension 
therapy should first emphasize life-style modifications such as weight 
loss, exercise, stress management, and sodium restriction.  
 CLINICAL FEATURES OF THE DIABETIC FOOT Symptoms  
Neuropathy    Ischaemia 
None      None 
Paresthesia     Claudication 
Pain      Rest pain 
Numbness 
Structural  Damage   Ischaemia 
Ulcer      Ulcer 
Sepsis     Sepsis 
Abscess     Gangrene 
Osteomyelitis  
Digital gangrene  
Charcot joint  
Management Of Diabetic  Foot Ulcers:  
Remove callus skin, treat infection, avoid weight-bearing, ensure 
good diabetic control, control oedema, undertake angiogram to assess 
feasibility of vascular reconstruction where indicated.  
Infections:  
Individuals with DM exhibit a greater frequency and severity of 
infection. The reasons for this increase include incompletely defined 
abnormalities in cell-mediated immunity and phagocytic function 
associated with hyperglycemia, as well as diminished vascularization  
secondary  to  long-standing  diabetes.  Hyperglycemia  likely  aids  the  
colonization and growth of a variety of organisms (Candida and other 
fungal species).  
Pneumonia, urinary tract infections,  skin and soft tissue infections 
are all more common in the diabetic population.  
 Dermatologic Manifestations  
The  most  common  skin  manifestations  of  DM  are  protracted  
wound healing and skin ulcerations.  
Diabetic dermopathy, sometimes termed pigmented pretibial 
papules, or “diabetic skin spots,” begins as an erythematous area and 
evolves into an area of circular hyperpigmentation . These lesions result 
from minor mechanical trauma in the pretibial region and are more 
common in elderly men with DM.  
Acanthosis nigricans (hyperpigmented velvety plaques seen on the 
neck or extensor surfaces) is sometimes a feature of severe insulin  
resistance and accompanying diabetes. Generalized or localized  
granuloma annulare  (erythematous plaques on the extremities or trunk) 
and scleroderma (areas of skin thickening on the back or neck at the  
site of previous superficial infections) are more common in the diabetic 
population. Lipoatrophy and lipohypertrophy can occur at insulin 
injection sites but are unusual with the use of human insulin. Xerosis and 
pruritis are common and are relieved by skin moisturizers.  
CLINICAL EXAMINATION OF THE PATIENT WITH 
DIABETES:  
1. Examination Of The Hands:  
Limited joint mobility  (sometimes  called  cheirorthropathy)  
may  be  present; this is the inability to extend (to 180) the 
metacarpophalangeal or interphalangeal joints of at least one finger 
bilaterally.   The effect can be demonstrated in the prayers sign.  
It causes painless stiffness in the hands, and occasionally affects the 
wrists and shoulders.  
Dupuytren’s contracture    is common in diabetes and may include 
nodules or thickening of the skin  and knuckle pads.  
Carpal tunnel syndrome   is common in diabetes and presents with 
wrist pain radiating into the hand.  
Trigger  finger  (flexor  tenosynovitis)    may  be  present  in  
people  with diabetes. 
Muscle-wasting/sensory changes may be present as features of a 
peripheral sensorimotor neuropathy, although this is more common in the 
lower limbs. 
2. Abdomen    Hepatomegaly 
3.Blood Pressure 
4.Axilla    Acanthosis nigricans 
5.Neek    Carotid puses, Bruits and thyroid  
Enlargement. 
6.Head Xanthelasma, Cranial nerve palsy and 
eye movements/ ptosis 
7. Examination of the Eyes: 
 Visual acuity 
 Distance vision using Snellen’s chart at 6 meters. 
 Near vision using standard reading chart. 
Impaired visual acuity may indicate the presence of diabetic eye 
disease, and serial decline may  suggest development or progression in 
severity. Lens opacification, look for the red reflex using the 
ophthalmoscope held 30 cm from the eye.  
The presence of lens opacities or cataract should be noted.  
Fundal examination:  
The pupils must be dilated with a mydriatic and examined in a 
darkened room.Features of diabetic retinopathy should be noted, 
including evidence of previous laser treatment which leaves 
photocoagulation scars.  
 8.Legs :  
 Muscle-wasting 
 Sensory abnormality  
 Granuloma annulare  
 Hair loss  
 Tendon reflexes  
 Necrobiosis lipoidica  
Neuropathic foot ulcer  
9.Examination of The Feet  
Inspection:  
Look for evidence of callus formation on weight-bearing areas, 
clawing of the  toes (a  feature  of  neuropathy,  loss  of  the  plantar  arch,  
discolouration  of  the skin,ischaemia), localised infection and the 
presence of ulcers.  
Deformity of the feet may be  present,  especially  in  charcot  
neuroarthropathy.Fungal  infection  may  affect  skin between toes, and 
nails.  
Circulation:  
Peripheral pulses, skin temperature and capillary refill should be 
tested.  
Sensation:  
 Light touch : use monofilaments.  
 Vibration sense: use 128Hz  tuning fork over big toe/malleoli.  
Pin-prick:  Use pin  
 Pain :  pressure over Achilles tendon. Proprioception  test 
 Position of big toe  
 Test for distal anaesthesia/hyperaesthesia in stocking distribution.  
Reflexes: Test plantar and ankle reflexes. 
DIETARY MANAGEMENT:  
Aims Of Dietary Management:  
 Abolish symptoms of hyperglycaemia  
 Reduce overall blood glucose and minimise fluctuations  
 Achieve weight reduction in obese patients to reduce insulin 
resistance, hyperglycaemia and dyslipidaemia  
 Avoid     hypoglycaemia associated with therapeutic agents 
(insulin,sulphonylureas). 
 Avoid   weight   gain   associated   with   therapeutic   agents  
(insulin,sulphonylureas, thiazolidinediones). 
 Avoid ‘atherogenic’  diets  or  those  which  may  aggravate  
diabetic complications (e.g. high protein intake in nephropathy) 
General Principles of Diet for Diabetes:  
Direct sugar intake in the form of refined carbohydrates should be 
totally avoided.   This includes table sugar, sweets, and jaggery. The total 
quantity of food must be restricted.  
There  is  no  need  to  change  over  from  rice  to  wheat  or  ragi  
as  the carbohydrate content of these different cereals is not significantly 
different. Green leafy vegetables and other low calorie foods can be taken 
in unlimited quantities.  
Addition of vegetable proteins in the form of bengal gram, green 
gram, have multiple benefits as they:  
 Increase the protein content 
 Increase the fibre content 
 Help to flatten sudden urges of blood sugar after a meal 
 Help to reduce serum lipid (fat) levels 
 The diet should help to maintain ideal body weight. 
 The diet should also help bring down the cholesterol triglyceride 
levels 
Types of Diabetic Diet 
The basis for types of diet  used in the treatment of diabetes; 
 Low energy, weight-reducing diets 
 Weight maintenance diets 
 Diets for insulin-treated diabetes 
Low-energy, weight-reducing diets  
Dietary prescriptions which cause a daily deficit of 500 kcal 
provide a realistic diet and induce a weekly weight loss of around 0.5 kg.   
Rapid weight reduction may provoke loss of lean body tissue, and care 
must be taken in the elderly to avoid the omission of essential nutrients, 
vitamins and minerals. Caloric restriction is essential for the obese 
diabetic patient treated with insulin and most oral agents, to try to 
minimise the weight gain which these can promote.   In such individuals, 
the omission of snacks between meals is often necessary  
Weight maintenance diets  
These are necessary for individuals with a normal body mass index   
and ideally should be high in carbohydrate and low in fat, with particular 
attention being paid to the type of fat ingested.  
Diets for Insulin-treated Diabetes  
A regular pattern of meals (and snacks) is important to maintain a 
constant daily intake of carbohydrate, and protects against 
hypoglycaemia. Simple information on the  relative  carbohydrate content  
of  foods  can  be provided  where  ever appropriate. Carbohydrate 
exchanges  (10 g portions) are currently not advocated as a method of  
controlling carbohydrate intake, as the exchange system makes no 
allowance for the glycaemic effect or for the fat content of foods.   
However, a good working knowledge of the carbohydrate content of 
foods is essential for practical management.   An insufficient  
dose of insulin for a meal with a large carbohydrate content leads to post-
prandial hyperglycaemia, while inadequate carbohydrate consumption 
risks hypoglycaemia.  
Diabetic Foods And Sweeteners:  
Low-calorie and sugar-free drinks are useful for patients with 
diabetes. These drinks usually contain non-nutritive sweeteners.   Many 
‘diabetic foods’ contain sorbitol or fructose which are relatively high in 
energy, may be expensive and may have gastrointestinal side-effects.  
They are not recommended as part of the diabetic diet.  
The non-nutritive sweeteners saccharin, aspartame, sucramate and 
acesulphame K are the most  widely  used  and  provide  means  for  
reducing  energy  intake  without  loss  of palatability.  
Of Energy Derived From Carbohydrate, Protein And Fat  
UK national   Recommended 
   diet     diabetic diet 
Energy Maintain BMI of 25 kg/m2  To approach 
BMI of22 kg/m2 
Carbohydrate    45 %    50 - 55% 
Fat    40%    30-35% 
Saturated fatty acids 17%    <10% 
Monounsaturated  11%    10-15% 
Polyunsaturated  6%    <10% 
Protein   12-15%   10-15% 
BMI = body mass index (weight [kg]/ height2 [m2])  
Education of The Patient About Dm And Exercise 
Diabetes Education:  
The diabetes educator is a health care professional (nurse, dietician, 
or pharmacist). The educator is a vital member of the comprehensive 
diabetes care program and educates the patient about a number of issues 
important for optimal diabetes care, including self-monitoring of blood 
glucose; urine ketone monitoring (type 1 DM); insulin administration; 
guidelines for diabetes  management during illnesses;  management of 
hypoglycemia;  foot  and  skin  care;  diabetes  management  before,  
during,  and  after exercise; and risk factor-modifying activities.  
Exercise:  
Exercise is an integral component of comprehensive diabetes care 
that can have  multiple  positive  benefits (cardiovascular  benefits,  
reduced  blood  pressure, maintenance of muscle mass, reduction in body 
fat, weight loss, etc.). For individuals with type  1 or type  2 DM, exercise 
is also useful for lowering  plasma  glucose (during  and  following  
exercise)  and  increasing  insulin sensitivity. 
Daily, regular physical exercise reduces insulin requirements.    
Sudden,  unaccustomed violent exercise, however, it likely to precipitate 
hypoglycemia especially in patients on insulin and should be taken 
prophylactically.   In the juvenile diabetic who has  omitted  insulin,  
vigorous  exercise  can  however precipitate ketoacidosis. Skeletal  
muscle is a major site for metabolic fuel consumption in the resting state, 
the increased muscle activity during vigorous, aerobic exercise greatly 
increases fuel requirements. Individuals with type 1DM are prone to 
either hyperglycemia or hypoglycemia  during exercise.  
To avoid exercise - related hyper-or hypoglycemia, individuals with 
type 1DM should:  
 Monitor blood glucose before, during, and after exercise. 
 Eat  a  meal 1  to 3  hr  before  exercise  and  the  supplemental 
 carbohydrate feedings at least every 30min during vigorous or 
prolonged exercise; 
 Decrease  insulin  doses(based  on  previous  experience)  before 
exercise and inject insulin into a non exercising area. 
 Learn individual glucose responses to different types of exercise 
and  increase  food  intake  for  upto 24hr  after  exercises,  
depending  on  intensity and duration of exercise. 
 In individuals with type  2DM, exercise-related hypoglycemia is  
less common but can occur in individuals taking either insulin or 
sulfonyl ureas.  
ON GOING ASPECTS OF COMPREHENSIVE DIABETES CARE:  
The morbidity and mortality of DM-related complications can be 
greatly reduced by timely and consistent surveillance procedures. 
Screening for dyslipidemia and hypertension should be performed 
annually.  
An  annual  comprehensive  eye  examination  should  be  
performed  by qualified optometrist or ophthalmologist.  
Guidelines for Ongoing Medical Care for Patients with Diabetes:  
 Self-monitoring of blood glucose (individualized frequency)  
 HbA1c testing (2-4 times/year)  
 Patient education in diabetes management (annual)  
 Medical nutrition therapy and education (annual)  
 Eye examination (annual)  
 Foot examination (1-2 times/year by physician; daily by patient)  
An annual foot examination should:  
a. assess blood flow, sensation, and nail care;  
b. look for the presence of foot deformities such as hammer or claw   
toes Charcot foot;  
c. identify sites of potential ulceration  
 Screening for diabetic nephropathy (annual)  
 Blood pressure measurement (quarterly)  
 Lipid profile (annual).  
 
 MATERIALS AND METHODS 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN 
CLINICAL STUDY ON MADHUMEGAM ( TYPE 2  DIABETES 
MELLITUS) WITH NEERIZHIVU CHOORANAM  
Study Design & Conduct of The Study: 
Study type : Randomised clinical trial 
Study place : OPD & IPD of PG Maruthuvam dept at Government Siddha  
Medical College & Hospital. Palayamkottai. 
Study period : 12 months 
Sample size: 40 patients 
Population And Sample: 
All NlDDM patients (fasting blood sugar ≥125  mg% and PP blood 
sugar ≥170 mg%) satisfying the inclusion and exclusion criteria 
mentioned below will be the population of study. NIDDM patients 
attending the OPD of PG Maruthvam department of Government Siddha 
Medical College Hospital, Palayamkottai, will be enrolled for this clinical 
research. 
Sample size: 
Sample size will be 40 patients. (20Op & 20 IP ) 
Treatment: 
Medicine Name: NEERIZHIVU CHOORANAM 
Dose 2 gm; 2 times a day; after food;  
Adjuvant Butter milk 
Duration 45  Days 
 Standard Operating Procedure For NEERIZHIVU CHOORANAM  
(Internal): 
Source of Raw Drugs: 
The source of raw drugs for preparation of  NEERIZHIVU 
CHOORANAM are purchased from a well reputed country shop and raw 
drugs are purified & prepared in PG - gunapadam lab of Government 
Siddha Medical College, Palayamkottai.  
Ingrdients of Neerizhivu Chooranam: 
Aavari virai (Cassia auriculala.linn ) 
Thetran vithai (Strychnous potatorum.linn )  
Kadukkai thol (Terminalia chebula.linn )  
Vilam pisin (Limonia acidissima.linn)  
Method of purification: 
Purification of thetran vidhai 
'I'hctran vidhai is soaked in cows milk for 3 hours and is washed 
with plain water.  
Purification of kadukkai thol: 
Kadukkai seed is removed and soaked in lime.juice and dried in 
sunlight.  
Purification of vilampisin: 
Vilampisin is clean well by removing the debris which adhere with it.  
Method Of Purification of Neerizhivu Chooranam: 
Ingredients:  
Aavarai vithai chooranam (cassia auriculata) 
 Vilam pisin chooranam (Limonia acidissima.linn)  
Thetran vithai chooranam ( Strychnous potatorum )  
Kadukkai thol chooranam ( terminlia chebula )  
Equal 
quantity 
Equal quanitity 
 Ingredients 1,2,3,4 are ground separately with iron martar till it 
attains consistency. The fine chooranam is mixed well and preserved in a 
clean and dry glass. 
Drug storge: 
The trial drug  Neerizhivu Chooranam is stored in a clean and dry 
glass bottles. 
Dispensing 
The chooranam is given in packets 
Subject selection 
As and when patients with symptoms of inclusion criteria reporting 
at OPD of PG Maruthuvam, Government Siddha Medical College, 
hospital  will be subjected to screening test & documentation will be 
done using screening proforma. 
Inclusion criteria: 
1. Age 35 to 65 yrs. 
2. Patients who are willing to attend the OPD regularly for the 48 
days will be included in the clinical trial. 
3. Patients who are willing to take treatment to take as IPD will be 
included in the clinical trial. 
4. Patients who are reporting with the clinical symptoms such as 
polyurea, polydipsia, polyphagia, weight loss will be included in 
the clinical trail. 
5. Patient who are reporting  with general tiredness, burning feet, 
generalized / genital pruritus, tingling and numbness, delayed / non 
healing wounds/ ulcer will be included. 
6. Blood sugar Fasting ≥ 125 % ; PP  ≥ 170 mg % will be included in 
the clinical trial 
 Exclusion criteria: 
1. Diabetic complications like neuropahy, retinopathy, etc. 
2. Hypertension 
3. Heart disease 
4. Kidney disease 
5. Liver diseases 
6. Pancreatic disease like acute pancreatitis, carcinoma of pancreas 
etc… 
7. Gestational diabetes, Type – 1 Diabetes 
8. Pregnancy and Lactation  
9. Patient not willing to give blood sample.  
Withdrawl criteria: 
1. Intolerance to the drug and development of adverse reactions 
during drug trial. 
2. Poor patient compliance & Defaulters. 
3. Patient turned unwilling to continue in the course of clinical trial 
4. Occurrence of any serious illness 
Tests and Assessments: 
a) Clinical Assessments: 
Polyuria, polydypsia, polyphagia, nocturia, tiredness, fatigue 
Sudden gain in weight, blurring of vision,pricking pain in both palm and 
soles,burning sensation in both soles and paresthesia in the feet,pruritis 
vulvae, balanitis. 
b) Investigation: 
Blood Test: 
TC DC, ESR, Hb, sugar (Fasting & PP) Lipid profile,Liver 
function test, Renal function lest. 
 Urine Test: 
Albumin,Sugar (Fasting and PP), Deposits 
Bile salt,Bile pigments, Urobilinogen. 
Clinical assessment &investigations-Siddha System: 
 Ennvagai thervugal-Naa,Niram, Mozhi, Vizhi, Sparism, Malam, 
Moothiram Naadi. 
Moothiram  
 NEERKURI - Niram, Edai, Manam, Nurai, Enjal. 
 NEIKURI 
 Motion Test - Ova, Cyst, Occult blood. 
METHODOLOGY 
STUDY ENROLLMENT 
In the Phase 11 study, patients reporting at the OPD with the 
clinical symptoms of Polyphagia, Polyuria, Polydipsia, nocturia etc.. will 
be examined clinically for enrolling in the study based on the inclusion 
and exclusion criteria. 
The patients who are to be enrolled would be informed (Form IV-
D) about the study, trial drug, possible outcomes and the objectives of the 
study in the language and terms understandable to them. 
After ascertaining the patient's willingness, informed consent 
would be obtained in writing from them in the consent form .(Form- 
IVA) 
All these patients will be given unique registration card in which 
patients' Registration number of the Study, Address, Phone number and 
Doctors phone number etc. will be given, so as to report easily should 
any complications arise. Complete clinical history, complaints and 
duration, examination findings-- all would be recorded in the prescribed 
Proforma in the history and clinical assessment forms separately. 
Screening Form- I will be filled up; Form I-A, Form -11 and Form -111 
will be used for recording the patients' history, clinical examination of 
symptoms and signs and laboratory investigations respectively. Patients 
would be advised to take the trial drug and appropriate dietary advice 
(Form IV-L:) would be given according to the patients' perfect 
understanding. 
Conduct of the study: 
The trial drug Neerizhivu Chooranam (Internal ) is given 
continuously for    45 days. 
For OP Patients, they should visit the hospital once in 7 days. At 
each clinical visit clinical assessment is done and prognosis is noted. For 
If Patients the drug is provided daily and prognosis is noted. 
For IP patients also clinical assessment is done daily. Laboratory 
investigations are done 15
°
' day, 30 & 48 th day of the trial. For IP 
patients, who is not in a situation to stay in the hospital for a long time is 
advised to attend the OPD for further continuation of treatment. After the 
end of the treatment also, the patient is advised to visit the OPD for 
another 2 months for follow-up. 
If any trial patient who fails to collect the trial drug on the 
prescribed day but wants to continue in the trial from the next day or two, 
he/she will be allowed , but defaulters of one week and more will not be 
allowed to continue and be withdrawn from the study with fresh case 
being inducted. 
DATA MANAGEMENT 
After enrolling the patient in the study, a separate file for each 
patient will be opened and all forms will be filed in the file. Study No. 
and Patient No. will be entered on the top of file for easy identification. 
Whenever study patient visits    OPD during the study period, the 
respective patient file will be taken and necessary recordings will be 
made at the assessment form or other suitable form. 
The screening forms will be filed separately. 
The Data recordings will be monitored for completion by HOD 
and adverse event by SrResearch Officer (Statistics). All forms will be 
further scrutinized in presence of Investigators by Sr.Research Officer 
(Statistics) for logical errors and incompleteness of data to avoid any 
bias. No modification in the results is permitted for unbiased reports. 
OUT COME: 
I Before treatment 2.After treatment 
ADVERSE EFFECT / SERIOUS EFFECT MANAGEMENT: 
If the trial patient develops any adverse reaction he/she would be 
immediately withdrawn from the trial and proper management will be 
given in OPD ofPG Maruthuvam Department of Government Siddha 
Medical College Hospital. 
ETHICAL ISSUES 
1. To prevent any infection while collecting the blood sample from 
the patient only disposable syringes , gloves with proper 
sterilization of lab equipments will be used. 
2. No other external & internal medicines will be used. There will be 
no infringement on the rights of patient. 
3.  The data collected from the patient will kept confidentially. The 
patient will be informed about the diagnosis, treatment and follow 
up. 
4. After the consent of the patient (through consent form) they will be 
enrolled in the study. 
5. Informed consent will be obtained from the patient explaining 
understandable language to the patient. 
6. Treatment would be provided free of cost. 
7. In condition of treatment failure, any other adverse reactions 
developed, patient will be given alternative treatment at the 
Government Siddha Medical College hospital, Palayamkottai. with 
full care through the end. 
ASSESSMENT FORM  
1. FORM I SCREENING & SELECTION PROFORMA  
2. FORM I A HISTORY PROFORMA ON ENROLLMENT  
3. FORM II CLINICAL ASSESSMENT ON ENROLLMENT  
4. FORM II A CLINICAL ASSESSMENT DURING & AFTER 
TRIAL  
5. FORM III LABORATORY INVESTIGATION ON 
ENROLLMENT & CONCLUSION OF TRIAL  
6. FORM IV A CONSENT FORM  
7. FORM IV B WITHDRAWAL FORM  
8. FORM IV C DRUG COMPLIANCE FORM  
9. FORM IV D PATIENT INFORMATION SHEET  
10. FORM IV E DIETARY ADVICE FORM  
11. FORM IV F ADVERSE REACTION FORM. 
 
 RESULTS AND OBSERVATIONS  
 The results were observed with respect to the following criteria by 
clinical study on 20 out –patients and 20 In-patients. 
1. Sex distribution 
2. Age distribution 
3. Kaalam distribution 
4. Constitution of the body 
5. Gunam 
6. Religion 
7. Occupation status 
8. Socio Economic status 
9. Habits 
10. Dietary pattern 
11. Paruva kaalam 
12. Thinai distribution 
13. Heriditary incidence 
14. Weight distribution 
15. Clinical manifestations  
16. Assocoiated symptoms 
17. Kosam 
18. Derangement of mukkutram  
 Derangement of vatham 
 Derangement of Pitham  
 Derangement of Kabham 
19. Ezhu udal kattugal 
20. Envagai Thervugal 
21. Neerkuri –Neikuri 
22. Investigation tables 
23. Grading of result 
1. Sex distribution 
Table – 1. Illustrates the Sex distribution and its relative percentage 
 Sex 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Male 13 65 9 45 
2. Female 7 35 11 55 
 
2. Age distribution 
Table – 2. Illustrates the Age distribution and its relative percentage 
S.No 
Age group in 
years 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. 31-40 1 5 - - 
2. 41-50 8 40 2 10 
3. 51-60 4 20 9 45 
4. 61-70 7 35 9 45 
5. 71-80 - - - - 
Above table Shows, the incidence is high in age between 51-70. 
 
3. Kaalam 
Table – 3.  Illustrates the Kaalam and its relative percentage 
S.No 
Age group in 
years 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Vatha Kaalam - - - - 
2. Pitha Kaalam 13 65 11 55 
3. Kapha Kaalam 7 35 9 45 
 
From the above study, the maximum number of cases were treated 
in Pitha Kaalam 
4. Constitution of the body 
Table – 4.  Illustrates the Constitution of the body and its relative 
percentage 
S.No 
Constitution of 
the body 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Vatha Thegi - - - - 
2. Pitha Thegi - - - - 
3. Kapha Thegi - - - - 
4. Thontha Thegi 20 100% 20 100% 
 
In all, the patients had Thontha Thegam 
5. Gunam 
Table – 5.  Illustrates the Gunam and its relative percentage 
S.No 
Gunam 
 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Sathuva gunam - - - - 
2. Rajao gunam 20 100% 20 100% 
3. Thamo gunam - - - - 
In this present study cent percent cases belongs to Rajogunam. 
 
6. Religion 
Table – 6.  Illustrates the Religion and its relative percentage 
S.No Religion  
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Hindu 15 75 19 95 
2. Christian 4 20 1 5 
3. Muslim 1 5 - - 
In this study, the maximum number of patients were Hindus. 
7. Type of work 
Table – 7.  Illustrates the Type of work and its relative percentage 
S.No 
 
Type of  work 
 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Sedentary worker 5 25 4 20 
2. Moderate worker 7 35 10 50 
3. Hard worker 8 40 6 30 
8. Socio Economic status 
Table – 8.  Illustrates the Socio Economic status and its relative 
percentage 
S.No 
 
Socio Economic 
status 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Poor 4 20 10 50 
2. Middle class 12 60 10 50 
3. Rich 4 20 - - 
 
From the above study, economically middle and poor class peoples 
were prone to diabetes. 
9. Habits 
Table – 9.  Illustrates the Habits and its relative  percentage 
S.No Habits 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Alcoholic 4 20 5 25 
2. Smoker 4 20 5 25 
3. Tobacco chewer 1 5 1 5 
4. None 15 75 14 70 
 
10. Dietary Pattern 
Table – 10.  Illustrates the Dietary Pattern and its relative  
percentage 
S.No 
 
Dietary Pattern 
 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Mixed diet 15 75 16 80 
2. Vegetarian 5 25 4 20 
 
From the above study it clearly shows that mixed diet is more 
prone to diabetes.  
11. Paruva Kaalam 
Table – 11.  Illustrates the Paruva Kaalam and its relative  percentage 
S.No 
Paruva 
Kaalam 
Months 
Out patients In patients 
No.of cases Percentage No.of cases Percentage 
1. Kaarkaalam Aavani,  
Purattasi 
10 50 11 55 
2. Koothir 
Kaalam 
Iyppasi, 
Karthigai 
2 10 4 20 
3. Munpani  
Kaalam 
Markazhi, 
Thai 
- - - - 
4. Pinpani 
Kaalam 
Masi, 
Panguni 
- - - - 
5. Elavenil 
Kaalam 
Chithirai, 
Vaikasi 
- - - - 
6. Muthuvenil 
Kaalam 
Aani, Aadi 8 40 5 25 
The above table shows most of the patients were treated in Kaarkalam.  
12. Thinai 
Table - 12   Illustrates the Thinai and its relative percentage. 
Sl.No. Thinai 
Out patients In patients 
No. of cases % No. of cases % 
1 Kurinji - - - - 
2 Mullai - - - - 
3 Marutham 20 100% 20 100% 
4 Neithal - - - - 
5 Paalai - - - - 
Above the table shows most of the patients were from marutha nilam. 
 
13. Family History 
Table - 13   Illustrates the Family history  and its relative percentage. 
Sl.No 
Hereditary 
incidence 
Out patients In patients 
No. of cases % No. of cases % 
1 Paternal 8 40 7 35 
2 Maternal 5 25 5 25 
3 Both 3 15 6 30 
4 No relevant history 4 20 2 10 
 
From the above study hereditary factors plays an important role in 
this disease. 
 14. Weight Distribution 
Table - 14   illustrates the Weight and its relative percentage. 
Sl.No. Weight 
Out patients In patients 
No. of 
cases 
% 
No. of 
cases 
% 
1 Over weight 5 25 6 30 
2 Ideal Weight 13 65 10 50 
3 Under Weight 2 10 4 20 
The above table shows the role of the obesity in the incidence of 
the disease. 
 
15. Clinical Manifestations features: 
Table-15: Illustrates the clinical manifestations and its relative 
percentage.  
S. 
No. 
Clinical Manifestations 
Out patients In patients 
No. of cases % No. of cases % 
1 Polyuria 20 100 20 100 
2 Polyphagia 8 40 20 100 
3 Polydipsia 16 80 20 100 
4 Nocturia 20 100 20 100 
5 Weight loss 7 35 10 50 
6 Pain 8 40 12 60 
7 Tiredness 5 25 20 100 
8 Peripheral Neuropathy 
(Numbness) 
10 50 5 25 
9 Ulceration - - - - 
10 Blurring vision - - - - 
All the patients get affected with polyuria and nocturia.  
16. Associated Symptoms : 
Table-16: Illustrates the Associated Symptoms and its relative 
percentage.  
S. 
No. 
Associated 
Symptoms 
Out patients In patients 
No. of cases % No. of cases % 
1 Balanitis - - - - 
2 Pruritis vulvae 4 20 3 5 
3 Arthropathy 4 20 5 25 
4 Giddiness - - - - 
5 Impotency - - - - 
6 Libido - - - - 
7 Constipation 5 25 4 20 
From the above study some patients had one or more symptoms as 
listed above.  
 
17. Kosam 
Table-17 : Illustrates the Kosam and its relative percentage. 
Sl.No. Kosam 
Out patients In patients 
No. of 
cases 
% 
No. of 
cases 
% 
1 Annamaya Kosam 20 100 20 100 
2 Pranamaya Kosam - - - - 
3 Manomaya Kosam 8 40 7 35 
4 Vingnanamaya Kosam 6 30 6 30 
5 Ananthamaya Kosam - - - - 
In all the patients , Annamayakosam gets affected. 
18. Disturbances in Vatha 
Table : 18 Illustrates the disturbances in Vatha and its relative 
percentage. 
Sl.No. Vatham 
Out patients In patients 
No. of cases % No. of cases % 
1 Pranan - - - - 
2 Abanan 15 75 16 80 
3 Viyanan 8 40 9 45 
4 Udhanan 17 85 16 80 
5 Samanan 12 60 15 75 
6 Nagan - - - - 
7 Koorman - - - - 
8 Kirukaran 5 25 7 35 
9 Devathathan 6 30 7 35 
10 Dhananjeyan - - - - 
 
Above table shows most of the cases had altered Abanan, Udhanan 
& Samanan 
19. Disturbances in Pitham 
Table.19 Illustrates the disturbances in Pitham and its relative 
percentage. 
Sl. 
No. 
Pitham 
Out patients In patients 
No. of cases % No. of cases % 
1 Anarpitham 15 75 20 100 
2 Ranjagapitham - - - - 
3 Prasakapitham 4 20 5 25 
4 Alosagapitham - - - - 
5 Sathagapitham - - 2 10 
 
Above the table shows most of the cases had altered anarpitham. 
20 . Disturbances in Kapham 
Table.20  Illustrates the disturbances in Kapham and its relative 
percentage. 
Sl. 
No. 
Kapham 
Out patients In patients 
No. of cases % No. of cases % 
1 Avalambagam - - - - 
2 Kilethagam 15 75 20 100 
3 Pothagam - - - - 
4 Tharpagam - - - - 
5 Santhigam 7 35 9 45 
Above the table shows most of the cases had altered Kilethagam 
 
21. Involvement of Ezhu Udalkattugal 
Table : 21. Illustrates the involvement of ezhu Udalkattugal and its 
relative percentage. 
Sl. 
No. 
Udalkattugal 
Out patients In patients 
No. of cases % No. of cases % 
1 Saaram 15 75 16 80 
2 Senneer 14 70 14 70 
3 Oon 6 30 7 35 
4 Kozhuppu - - - - 
5 Enbu 8 40 7 35 
6 Moolai - - - - 
7 Sukkilam/ 
Suronitham 
- - - - 
From the above study all the patients had altered Saaram . 
 22. Envagai Thervugal 
Table 22 :  Illustrates the condition of envagai Thervugal and its 
relative percentage. 
Sl.No. 
Envagai Thervugal 
 
Out patients In patients 
No. of cases % No. of cases % 
1 Naadi 20 100 20 100 
2 Sparisam 10 50 5 25 
3 Naa 12 60 17 85 
4 Niram - - - - 
5 Mozhi - - - - 
6 Vizhi - - - - 
7 Malam 5 25 4 20 
8 Moothiram 20 100 20 100 
 
In all the patients, Moothiram get affected. All the patients showed 
Pitha Kalapu Naadi (Pitha vatham and Vathapitham). 
23. Neerkuri – Neikuri 
Table : 23  Illustrates the Neerkuri - Neikuri and its relative percentage. 
Sl.
No 
Type of test result 
Out patients  In patients 
No. of cases % No. of cases % 
1 Neerkuri  
(straw yellow in colour & clear) 
20 100 20 100 
2 Neikuri     
a. Aravena neendathu                      11 55 14 70 
b. Aazhi pol paraviyathu  - - - - 
c. Muthothu nindrathu  4 20 3 15 
d. Thonthaneer  5 25 3 15 
 In this present study of neerkuri showed straw yellow in colour and 
honey odour. Most of the patients had Vaathaneer. 
24. Assessment of Result : 
Table : 24  Illustrates the Assessment of Results and its relative 
percentage. 
Sl.No. Result 
Out patients In patients 
No. of cases % No. of cases % 
1 Good Response 17 85 18 90 
2 Moderately 
Response 
3 15 2 10 
3 Poor Response - - - - 
 
Most of the patients showed good results. At the end of the 
treatment the inpatients were discharged and they were advised to follow 
up treatment in OPD of  P.G. Department of  maruthuvam.  
 
 
 
 
 
 DISCUSSION 
Madhumegam is a group of common metabolic disorder 
characterised by excessive urination and hyperglycemia. The signs and 
symptoms of madhumegam are well defined  by Yugi munivar in the 
book of  Yugi vaidhya chinthamani800. If neglected to treat the disease 
Madhumegam, it  produces various type of complications. So the author 
has choosen the disease to control madhumegam and prevent the 
complications of madhumegam. “Madhumegam” which is mentioned in 
siddha literatures is almost correlated with type 2 diabetes mellitus (Non 
insulin dependent diabetes mellitus-NIDDM) as in allopathic system of 
medicine. 
The present study is a preliminary one. Twenty patients of both 
sexes were observed as out-patient and twenty patients were admitted as 
In-patient in the PG maruthuvam department of Govt. Siddha medical 
college, Palyamkottai. After careful analysis of their  clinical symptoms, 
under the supervision of Professor, Reader  and Assistant Lecturers of the 
maruthuvam Department,  all the patients were administered with the trial 
medicines regularly.  The observations were recorded and discussed 
under the following parameters.  
1. Sex Distribution:- 
Among 20 out - Patients   65% of cases were males and 35% of 
cases were females.  
Among 20 In-Patients 45% of cases were males and 55% of cases 
were females. 
2. Age distribution:- 
Among 20 out – Patients 5% were in the age group between 31-
40,40% cases were in the age group between 41 – 50,20% cases were in 
the age group between 51-60,35% cases were in the age group between 
61 -70. 
Among 20 In patients 10% were in the age group between 41-50. 
45% were in the age group between 51-60, 45% cases were in the age 
group between 61-70. 
3. Kaalam: 
Among 20 out – Patients no cases were reported in vatha kaalam, 
65% of cases belongs to pitha kaalam and 35% of cases belongs to 
kaphakaalam.  
Among 20 In-Patients no cases in vathakaalam 55% cases belongs 
to Pithakaalam 45% of cases belongs to Kapha Kalam.  
The maximum number of cases were reported in pithakaalam. 
4. Thegi: 
Among 20 In-Patients and 20 out patients cent percent had thontha 
thegam as their bodies were constituted by mixed characters of vatha, 
pitha and kabham.  
5. Gunam: 
In this present study cent percent cases belongs to Rajogunam.  
6. Religious distribution: 
Among 20 out Patients 75% were Hindus, 20% were Christians 
and 5% Muslim. 
Among 20 In – Patients 95% were Hindus and 5 % cases were 
christian. 
7. Occupational status: 
In 20 Out patients study 25% cases were sedantary worker, 35% 
cases were moderate worker, 40% cases were hard worker. 
In 20 In patients study 20% cases were sedentary worker, 50% 
cases were moderate worker 30% cases were Hard worker.   
 8. Socio-economic status: 
Among 20 out patients 20% were from poor socio economic 
status,60% cases were from middle class family and 20% of cases were 
form Rich Family. 
Among 20 In patients 50% cases were from poor socio - economic 
status, 50% cases were from middle class family. 
From the above study economically poor and middle class people 
were more prone to diabetes. 
9. Habits: 
In 20 out patient study 20% cases had a habit of alcohol, 20% cases 
had a habit of smoking 5% cases had a habit of Tobacco chewing and 
75% of cases had none of these habits.  
In 20 In patients study 25% cases had a habit of alcohol, 25% cases 
had a habit of smoking 5% cases had a habit of Tobacco chewing and 
70% of cases had none of these habits. 
10. Dietary Pattern: 
In 20 out patients study 75% of cases had a habit of mixed diet and 
25% of cases had a habit of vegetarian diet. 
In 20 In patients study 80% cases had habit of mixed diet and 20% 
cases had a habit of vegetarian diet. 
From the above study it clearly shows that mixed diet is more 
prone to madhumegam. 
11. Paruvakaalam: 
In 20 out-patients study 50% cases were observed in kaarkalam , 
10% cases were observed in koothir kalam and 40% cases were observed 
during muthuvenil Kaalam. 
In 20 In patients study 55% cases were observed during 
kaarkaalam 20% cases were observed during  Koothirkkalam and 25% 
cases were observed during muthuvenil kaalam.  
During this study majority of cases were identified in muthuvenil 
kaalam. 
12. Thinai: 
Among 20 In –Patients and 20 out – patients cent percent were 
from marutham.  
13. Family history: 
In 20 out-patients study 40% cases had paternal positive family 
history, 30% cases had maternal positive family history 15% cases had 
both paternal and maternal family history and 25% had no relevant 
history.  
In this present study out of 20 In patients 35% cases had paternal 
positive family history, 25% cases had maternal positive family history, 
30% cases had both paternal and maternal family history, and 10% had 
no relevant history. 
From the above study hereditary plays and important role in this 
disease.  
14. Weight distribution: 
In 20 out patients study 25% cases were overweight, 65% cases 
were ideal weight and 10% cases were under weight. 
In 20 in patients study 30% cases were overweight, 50% cases 
were ideal weight and 20% cases were under weight. 
From the above study obesity plays an important role.  It is also 
prevalent in ideal and underweight people.  
15. Clinical manifestations: 
In 20 out patients cent percent cases had polyuria, and nocturia, 
40% cases had polyphagia, 80% cases had polydipsia, 35% cases had 
weight loss, 50% cases had peripheral Neuopathy, 25% cases had 
Tiredness.  
In 20-In patients study cent percent cases had polyuria and Poly 
phagia,  polydipisa, and Nocturia, 50% cases had weight loss, 20% cases 
had tiredness, 60% of cases had pain.  
Some patients had one or two or many symptoms as listed above . 
16. Associated symptoms: 
In 20 out patients 20% cases had pruritis valvae. 20% cases had 
arthropathy and 25% cases had constipation . 
In 20 In- Patients 25% cases had arthropathy and5% cases had 
pruritus vulvae and 20% had constipation . 
Some patients had  two or many symptoms as listed above.  
17. Kosam: 
In 20 out patients Annamayakosam altered in cent percent patients,  
Manomayakosam was altered in 40% patients, Vingnanamayakosam was 
altered in 30% patients. 
In 20 In patients study Annamaya kosam was affected in cent 
percent patients, Manomayakosam was altered in 35% patients, 
Vingnanamayakosam was altered in 30% patients. 
18. Disturbances in Vatham: 
In 20 out patients study 75%  of cases had altered abanan 40% of 
cases had altered Viyanan and  85% of cases had altered udhanan, 60% of 
cases had altered samanan and 25% cases had altered kirukaran and  30 
% of the cases had altered Devathathan. 
In 20 In patients study 80%  of cases had altered Abanan and 
Udhanan 45% has altered   Viyanan, 75% has altered Samanan and 35% 
of cases had altered Kiruharn and Devathathan. 
19. Disturbances in pitham: 
In 20 out patients 75% cases had altered Anarpitham 20% of cases 
had altered prasagapitham. In both Ip and OP study most of the cases had 
altered Anarpitham. 
In 20 In patients study 100% of cases had Altered Anarpitham, 
25% of cases had altered  prasagapitham, 10% of cases had altered 
sathaga pitham.  
20. Disturbances in Kabham:- 
In 20 out patients study 75% of cases had altered kilethagam, 35% 
of cases had altered  santhigam. 
In 20 in patients study cent percent of cases had altered Kilethagam 
and 45% of cases had altered santhigam. 
21. Ezhu udalkattugal:-  
In 20 out patients study saaram was affected in 75%  cases. Seneer 
was affected in 70% of the cases. oon was affected in 30% of cases, enbu 
was affected in 40% of cases. 
In 20 in patients study 80%  of cases had altered saaram.  70% of 
the cases has altered seneer. Oon was affected in 35% of cases,Enbu was 
affected in 35% of cases. Affected saaram produces general debility  
 Affected oon produces ill built.  
 Affected Enbu produces pain in the knee joint and shoulder joint. 
22. Envagai Thervugal:- 
In 20 Out patients study moothiram and naadi was affected in cent 
percent of cases. Naa was affected in 60% of cases and sparisam was 
affected in 50% of cases, malam was affected in 25% of cases. 
In 20 In patients study mothiram and naadi  was affected in cent 
percent of cases. Sparisam was affected in 25% of cases. Naa was 
affected in 85% of cases and malam was affected in 20% of cases. 
23. Neerkuri and Neikuri:- 
In this present study urine sample of cent percentage of both IP and 
OP patients showed straw yellow in colour and clear and honey odour. 
The drop of oil lengthens like a snake or ring or pearl in the patients urine 
sample it indicates Vathaneer, pitha neer, kabhaneer respectively. 
In O.P study 55% spreads like snake, 20% spreads like pearl, 
thontha neer present in 25% of cases. In I.P study 70% spreads like snake. 
(Vathaneer) 15% spreads like pearl (kabha Neer) and thonthaneer present 
in 15% of cases.  
24. Gradation of results: 
Among out patients 90% showed good result and 10% showed fair 
result, among in patients 85% showed good result, 15% showed Fair 
result,  
After the treatment all the in patients and out patients had 
significant symptomatic improvement. Frequency of micturition was 
found to be reduced. Especially excessive appetite, numbness and 
burning sensation on foot were also reduced. 
At the end of the treatment the inpatients were discharged and they 
were advised to follow up treatment in P.G. Department of Maruthuvam 
O.P for further management.  
 
 SUMMARY 
 Madhumegam is the most commonly occurring disease which 
affects both sexes, the age group above 40yrs. By its prevalance it seeks 
proper medical attention in the early stage, otherwise it leads to several 
complications like diabetic retinopathy, neuropathy, nephro-angiopathy 
and diabetic foot ulcer etc.  
These complications are prevented by controlling this disease by 
proper treatment and diet management. So the author had chosen this 
disease and had provided more efforts.  
 The disease is well correlated with “Diabetes mellitus” (NIDDM) 
due to its classical signs and symptoms.  
“Neerizhivu choornam” was taken as a trial medicine for this 
dissertation work. The aetiology, pathology, classification, clinical 
features, diagnosis, treatment and prevention were collected from 
available literatures from both Siddha system and modern system of 
medicine.  
 In this study 40 patients of both sexes at 30 – 70 different age 
groups with classical clinical symptoms were selected and 20 patients 
were taken as in patients and another 20 patients were taken as out 
patients.  
All the patients were examined by Siddha methodology such as 
poriyal arithal, pulanal arithal, vinavuthal, envagai thervugal and naadi 
paritchai. 
 According to modern methodology, routine investigations like 
blood, urine and motion were analysed in all cases. 
The trial medicine Neerizhivu choormam was administered to all 
the selected patients, in the dose of 2 gm ; 2 times a day ; with Butter 
milk. 
 Among O.P and I.P patients, all cases showed significant 
symptomatic improvement.  
 Poly uria, nocturia, excessive appetite, numbness, tiredness and 
burning of foot were also reduced. 
 Blood sugar and urine sugar was with in normal limit for 85% of 
cases, whereas 15% of cases showed moderate decrease in blood and 
urine sugar. 
 All the durgs in Neerizhivu  choornam are purely herbal. The 
potent antidiabetic drugs are Aavarai, kadukaai, Thetran vithai and vilam 
pisin as per siddha literature. 
 Biochemical Analysis of Neerizhivu choornam showed the 
presence of calcium,sulphate, ferrous iron, unsaturated compounds, 
tannic  acids and reducing sugar.  
Pharmacological study – The trial drug neerizhivu chooranam was oral 
anti – hyperglycemic effect was observed. 
 CONCLUSION 
 In this research clinical results found to be good in 85% of IP 
cases, 90% of Op cases, Fair in 15% of IP cases, 10% of Op cases.  
 Clinically the trial medicine was very effective to the suffering 
patients and relieved from the symptoms.  
 Further follow up of all these patients showed efficacy of medicine. 
 Clinical study showed no adverse effects of trial medicine during 
this study. 
 So it is concluded that madhumegam is controlled by  Neerizhivu 
chooranam. 
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PREPARATION AND PROPERTIES OF TRIAL 
MEDICINE NEERIZHIVU CHOORANAM 
Preparation: 
 Dried seeds of Aavarai, Thetran, and outer covering of kadukkai, 
(un ripe fruit rind of Terminalia chebula) vilam pisin are collected and 
finely powdered and filtered by vasthra kayam process (filtration through 
cloth). Now the medicine is ready to use.  
Dose:  
 2gm; two times a day; after food. 
Adjuvant: 
 Butter milk 
Uses: 
 Madhumegam 
Expiry: 
 3 month from the time of preparation. 
Reference: 
 The pharma copoeia of siddha Research Medicines - specific 
medicine (Page No. 52) 
Drug Description: 
Cassia auriculata -  Mthiu 
NtWngah;   : Mtiu> Mtpiu> MFyp> VkGl;gp> Nkfhhp>  
jyNghlk; . 
gad;gLk; cWg;Gfs;: ,iy> G+> gl;il> tpij> Nth;> gprpd;. 
 
  Rit  : Jth;g;G 
  jd;ik : jl;gk; 
  gphpT  : ,dpg;G 
tpijapd; nra;if 
 Fsph;r;rpAz;lhf;fp 
 nre;ePhpsf;fp 
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nghJFzk;  
‘nrhy;Yjw;F kl;Nlh njhiyahj NkfePh; 
vy;yh nkhopf;Fk; nkhptfw;W - nky;y tr 
khthiug; gk;guk;Ngh yhl;Le; njhopyzq;Nf 
ahthiu %yp aJ” 
- Njiuah; Fzt;;; hflk; ;;;  
Uses: 
 Used in Diabetes 
 Urinary Tract Diseases 
 Leucorrhoea 
 Dysentry 
 Eye diseases 
2. Strychnos Pota torum – Njw;whd; 
NtW ngah;   :  ,y;yk;> rpy;yk;> fjfk;> NjW 
gad;gLk; cWg;Gfs; : gok;> tpij  
Rit    : ifg;G 
jd;ik   :  ntg;gk; 
gphpT    : fhh;g;G 
tpijapd; nra;if 
 clw;Njw;wp 
 cukhf;fp 
 grpj;jPj; J}z;b 
 cs;soyhw;wp 
nghJFzk;;;; 
 ‘Njw;whd; tpijaJ jhd; jPgdj;ijg; Nghf;Fk; 
  Mw;wkpU fz;Zf; fUkUe;jhk; - $w;wh  
  apUj;Jq; fphpr;ruj;ij vq;Fkpyh Njhl;Lq; 
 FUj;Jt Kz;lhf;Fq; Fwp” 
- mfj;jpah; Fzghlk; 
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Medicinal Uses: 
 Leucorrhoea 
 Veneral Diseases 
 Polyphagia 
 Burning micturation  
 Eye Diseases 
 Chronic Diarrhoea 
 Bronchitis 
 Anaemia and Oedema  
3. Terminalia Chebula – fLf;fha;j; Njhy;; ; ; ;; ; ; ;; ; ; ; 
NtW ngah;  :  mq;qzk;> mguzk; mhpjfp> tdJh;f;fp>  
gj;jpak;> fL> thpf;fha; 
gad;gLk; cWg;G :  gpQ;R> gok; 
Rit : Kf;fpa Rit Jth;g;G mj;Jld; rpwpJ  
,dpg;G> Gspg;G> fhh;g;G> ifg;G  
Njhy;   : fhh;g;G Rit 
nghJ Fzk;:;;;  
“ jhil fOj;jf;fp jhY Fwpap tplg; 
gPil rPypgjKw; Ngjp Klk; - Milnal;lhj;  
J}ykpb Gz;thj Nrhzp fhkhiy apuz;  
lhykpb Nghk; thpf;fhahy;”   
 Medicinal Use: 
 Poly uria 
 Opthalmic Diseases 
 Anaemia, Anorexia 
 Liver Diseases 
 Diarrhoea and Dysentry 
 It has a nourishing and restorative effect on the central nervous 
system. 
 It cures the tingling sensation in feet.  
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4. Limonia acidissima – tpsh kuk;;;; 
NtW ngah;   : fbg;gif> fgpj;jk;> tpsT> nts;spy;  
gad;gLk; cWg;Gfs; : ,iy>fha;> gok;> go XL> gprpd; 
gprpdpd; nra;if   : cs;soyhw;wp – Demulcent 
nghJ Fzk;:;;;  
 ‘ ey;y tpshk;gprpid ew;ghfQ; nra;jUe;j  
  njhy;iy ajprhue; njhiyt njd;Nwh - nky;ypauhy;  
  te;j nts;is jd;DlNd khjh; ngUk;ghLk;  
  ce;J ePh;g; Nghf;FNkhk; cd;” 
- mfj;jpah; Fzthflk;; ; ;; ; ;; ; ; 
Medicinal Uses: 
 It cures diabetes  
 Used in Diarrhoea and Dysentry 
 Uesful in Leucorrhoea and Menorrhogia. 
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BIO-CHEMICAL ANALYSIS 
NEERIZHIVU CHOORANAM 
PREPARATION OF  THE  EXTRACT 
 5 gms of the drug was weighed accurately and placed in a 250ml 
clean beaker.  Then 50ml of distilled water is added and dissolved well.  
Then it is boiled well for about 10 minutes.  It is cooled and filtered in a 
100ml volumetric flask and then it is make up to 100ml with distilled 
water.  This fluid is taken for analysis.  
QUALITATIVE ANALYSIS 
S.No. EXPERIMENT OBSERVATION INFERENCE 
1. 1. TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube.  To this add 2ml of 4% 
ammonium oxalate Solution.  
A white 
precipitate is 
formed.  
Indicates the 
presence of 
calcium. 
2. TEST FOR SULPHATE 
2ml of the extract is added to 
5% Barium chloride solution.  
A white 
precipitate is 
formed.  
Indicates the 
presence of 
sulphate. 
3. TEST FOR CHLORIDE 
The extract is treated with 
Silver nitrate Solution.  
No white 
precipitate is 
formed.  
Absence of 
chloride. 
4. TEST FOR CARBONATE 
The substance is treated with 
Concentrated HCL. 
No brisk 
effervessence is 
formed.  
Absence of 
Carbonate. 
5. TEST FOR STARCH 
The extract is added with weak 
iodine solution.  
No blue colour is 
formed.  
Absence of  
starch. 
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6. TEST FOR FERRIC IRON 
          The extract is acidified 
with Glacial acetic acid and add 
Potassium ferro cyanide. 
No blue colour is 
formed.  
Absence of 
ferric Iron.  
7. TEST FOR FERROUS IRON 
         The extract is treated with 
Concentrated nitric acid and 
Ammonium thio cyanate 
solution.  
Blood red colour 
is formed.  
Indicates the 
presence of 
ferrous Iron. 
8. TEST FOR PHOSPHATE 
         The extract is treated with 
ammonium Molybdate and 
concentrated nitric acid.  
No yellow 
precipitate is 
formed.  
Absence of 
phosphate.  
9. TEST FOR ALBUMIN 
         The extract is treated with 
Esbatch’s Reagent.  
No yellow 
precipitate is 
formed.  
Absence of 
Albumin.  
10. TEST FOR TANNIC ACID 
         The extract is treated with 
ferric Chloride.  
Blue black 
precipitate is 
formed.  
Indicates the 
presence of 
Tannic acid.  
11. TEST FOR 
UNSATURATION 
         Potassium permanganate 
solution is added to the extract. 
It gets 
decolourised.  
Indicates the 
presence of 
unsaturated 
compound.  
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12. 
TEST FOR THE 
REDUCING SUGAR 
         5ml of Benedict’s 
qualitative Solution is taken in a 
test tube and allowed to boil for 
2 mins and add 8-10 drops of 
the extract and again boil it for 
2 mins.  
Colour change 
occurs. 
Indicates the 
presence of 
Reducing sugar.  
13. TEST FOR AMINO ACID 
         One or two drops of the 
extract is placed on a filter 
paper and dried it well. After 
drying 1% Ninhydrin is sprayed 
over the same and dried it well. 
No violet colour is 
formed.  
Absence of 
Amino acid.  
14. TEST FOR ZINC 
         The extract is treated with 
Potassium ferrocyanide.  
No white 
precipitate is 
formed. 
Absence of 
Zinc.  
 
INFERENCE  
 The given sample of NEERIZHIVU CHOORANAM indicates the 
presence of Calcium, Sulphate, Ferrous Iron, Reducing Sugar, 
Unsaturated Compounds, and Tannic Acid.  
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ANTI-HYPERGLYCEMIC EFFECT OF NEERIZHIVU 
CHOORANAM IN EXPERIMENTAL DIABETES AND THEIR 
EFFECTS ON KEY METABOLIC ENZYMES INVOLVED IN 
CARBOHYDRATE METABOLISM. 
INTRODUCTION 
 Diabetes mellitus is a metabolic disorder in which the body does 
not produce or properly utilize insulin. It causes disturbance in 
carbohydrate, protein and lipid metabolism and complications such as 
retinopathy, microangiopathy and nephropathy. In practical terms, 
diabetes mellitus is a condition in diabetes, a profound alteration in the 
concentration and composition of lipid occurs. The global figure of 
people with diabetes set rise from the current estimate of 150-220 million 
in 2010 and 300 million in 2025.  
Despite the immense strides that have been made in the 
understanding and management of diabetes the disease and disease 
related complications are increasing unabated. In spite of the presence of 
known anti-diabetic medicine in the pharmaceutical market, remedies 
from siddha medicine are used with success to treat this disease. Many 
siddha preparation  for diabetes are used throughout the world and there 
is an increasing demand by patients to use the chooranam with anti-
diabetic activity. 
Siddha drugs are used widely even when their biologically active 
compounds are unknown, because of their effectiveness, minimal side 
effects in clinical experience and relatively low cost. There are several 
siddha preparation are used in the treatment of diabetes and diabetic 
associated hyperlipidemia, among this siddha preparation the new 
preparation Neerizhivu chooranam is selected for the present study. 
The present investigation is undertaken to the study the effect of 
Neerizhivu chooranam on changes in Body weight, Plasma glucose, 
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RBC, WBC, HB, Platelets, Hepatic glucokinase & hexokinase, Glucose-
6-phosphate and Glycogen content. 
EXPERIMENTAL MODELS 
                For the study of anti-diabetic and their effect on key metabolic 
enzymes involved in carbohydrate metabolism, an experimental model is 
selected in such a way that it would satisfy the following: 
 The animal should develop hyperglycemia rapidly. 
 Pathological changes in the site of induction should result from 
pancreatitis or damage of   β-cells. 
 The symptoms should be ameliorated or prevented by a drug 
treatment effective in human beings. 
 The drug tested must be administered orally. 
 Drug dosage should approximate the optimum therapeutic range 
for human, scaled the test animal weight. 
Selection of Laboratory Model 
 Animals such as sheep, cats, dogs, rats, rabbit and guinea pigs 
have been used in the experimental study of pancreatitis. 
 Rats are the most common model used in the study of diabetics. 
 In the presence study the rats have been used because, the 
glucose metabolism of rat resembles human glucose metabolism 
believed to contribute to diabetes. 
MATERIALS AND METHODS 
Materials: 
Animals    : Albino wistar rats (180-200gm) 
Drugs         : Neerizhivu chooranam & Glipizide (Micro Labs,         
    Hosur) 
Chemical:  Alloxan monohydrate (S. D Fine. Chem. Ltd, Mumbai) 
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Selection & acclimatization of animals:        
           Wistar strains of  albino rats weighing between 180-220gm are 
used for this study. The animals were housed in large spacious cages and 
they were fed with commercial pellets and access to water ad libitum. 
The animals were well acclimatized to the standard environmental 
condition of temperature (22
0
c ± 5
0
c) and humidity (55 ±5%) and 12 hr 
light dark cycles throughout the experimental period. 
INDUCTION OF DIABETES MELLITUS 
 Diabetes mellitus is induced in wistar rats by single intraperitoneal 
injection of freshly prepared solution of Alloxan monohydrate (150mg/kg 
BW) in physiological saline after overnight fasting for 12hrs.[1] 
Alloxan is commonly used to produce diabetes mellitus in 
experimental animals due to its ability to destroy the β-cells of pancreas 
possibly by generating the excess reactive oxygen species such as H202, 
02 and H0
-
. The development of hyperglycemias in rats is confirmed by 
plasma glucose estimation 72 hrs post alloxan injection. The rats with 
fasting plasma glucose level of 200-260mg/dl were used for this 
experiment.
 
Experimental procedure: 
IAEC, K.M.College of Pharmacy, Madurai has approved this 
experimental procedure. 
In the experiment a total of 30 rats (24 diabetic surviving rats & 6 
normal rats) were used. Diabetes was induced in rats 3 days before 
starting the experiment. The rats were divided into 5 groups after the 
induction of alloxan diabetes. In the experiment 6 rats were used in each 
group. 
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TREATMENT PROTOCOL 
 Group-I:  (Normal control) consist of normal rats given with 
10ml/kg of normal saline, orally. 
 Group-II:  (Toxic control) Diabetic control received 150mg/Kg of 
Alloxan monohydrate through I.P. 
 Group-III:  (positive control) Diabetic rat received Glipizide 
(10mg/Kg i.p)
[2]
 for 28 days, orally. 
 Group-IV: (Treatment group) Diabetic rat received low dose 
(200mg/Kg) of Neerizhivu chooranam daily using intra-gastric 
tube for 28 days. 
 Group-V: (Treatment group) Diabetic rat received high dose 
(400mg/Kg)
 
of Neerizhivu chooranam daily using intra-gastric tube 
for 28 days. 
METHODOLOGY 
Sample collection:            
            After 28 days of treatment, the blood glucose level and body 
weight was measured. Then blood was collected retro-orbitally from the 
eye under light ether anaesthesia using capillary tubes. Blood was 
collected in fresh vials containing EDTA as anticoagulant agents and 
plasma was separated in a T8 electric centrifuge at 2000 rpm for 2 
minute. Then animal was sacrificed by decapitation. Liver and pancreas 
were immediately dissected out, washed in ice-cold saline to remove the 
blood. And liver was used for estimation of enzyme activity while 
pancreas was subjected to histopathological studies. 
BIOCHEMICAL ANALYSIS 
Estimation of blood glucose 
         Blood glucose was estimated by commercially available glucose kit 
(One Touch Ultra) Johnson Johnson based on glucose oxidase method.
 [3] 
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Hepatic glucokinase and hexokinase activity 
         The liver was perfused with ice cold 0.15M Kcl and 1mM EDTA 
solution and homogenized with twice its weight of ice cold buffer (0.01 
cysteine and 1mM EDTA in 0.1 ml Tris-HCL,pH 7.4) and centrifuged  
for 20 minute at 4
0
C. Glucose phosphorylation was assayed by means of 
the glucose 6 phosphate dependent spectrophotometric method. 
[4] 
Glucose-6-phosphatase activity 
        The liver was homogenized with 40 times its weight of ice cold 
buffer (0.1 citrate-KOH, pH 6.5) and filtered through cheese cloth. 
Glucose-6-phosphatase activity was measured by phosphate release by 
the method Marjorie. The determination of phosphoric acid concentration 
in assay mixture was done colorimetrically. 
[5] 
Glycogen Content 
          The tissue sample was digested by hot concentrated 30% KOH and 
treated with anthrone reagent. Glycogen content was determined 
colorimetrically. 
[6] 
Haemetological and Biochemical parameters 
          Blood samples were assessed for RBC, WBC, HB, and Platelets 
with an auto analyzer (MISPA-EXCEL, Japan). 
Histopathological examination 
         Pancreas tissue section was fixed in 4g/L formaldehyde and 
embedded in paraffin. Paraffin section was then stained with 
Hematoxylin-eosin. 
[7]
 Each sample was observed at 400X magnification 
and scored according to the injuries.
 [8]
 
Statistical analysis- 
        The data for different biochemical parameters were analyzed by 
using ONE WAY ANOVA followed by Newman Keul’s multiple range 
test. 
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TABLE NO: 1 
Effect of body weight of normal and experimental animals in each group 
GROUPS INITIAL BODY  
WEIGHT (gram) 
FINAL BODY 
WEIGHT (gram) 
GROUP I (G 1) 212.22 ± 4.16 216.30 ± 4.58 
GROUP II (G 2) 200.95 ± 4.52 150.45 ± 2.10*
a
 
GROUP III (G 3) 214.12 ± 4.25 222.30 ± 4.69*
b
 
GROUP IV (G 4) 210.20 ± 5.28 226.36 ± 4.56*
b
 
GROUP V (G 5) 212.26 ± 5.20 220.6 ± 4.23*
b
 
G1- Normal Control; G2- Diabetic Control; G3- Positive control 
(Glipizide);  
G4- Treatment group 200mg/kg;  G5- Treatment group 400mg/kg. 
 Values are expressed as Mean ± SEM. 
 Values were find out by using ONE WAY ANOVA followed by 
Newman Keul’s multiple range tests. 
 *a values were significantly different from normal control (G 1) at 
(P<0.01) 
 *b values were significantly different from diabetic control (G 2) at 
(P<0.01) 
TABLE No: 2 
Effect of 4 week treatment with various doses of Neerizhivu chooranam 
on glucose levels (mg %) in alloxan diabetic rats. 
GROUPS 0TH DAY 14TH DAY 28TH DAY 
GROUP I (G 1) 76.8 ± 5.32 75.80 ± 4.75 70.35 ± 4.28 
GROUP II (G 2) 158.68 ± 5.32 172.26 ± 6.30*
a
 216.6 ± 7.28*
a
 
GROUP III (G 3) 190.6 ± 5.26 146.45 ± 4.30*
b
 136.72 ± 3.72*
b
 
GROUP IV (G 4) 196.32 ± 3.88 157.32 ± 4.44*
b
 150.22 ± 4.50*
b
 
GROUP V (G 5) 192.58 ± 4.25 160.25 ± 4.30*
b
 148.30 ± 4.15*
b
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G1- Normal Control; G2- Diabetic Control; G3- Positive control 
(Glipizide);  
G4- Treatment group 200mg/kg; G5- Treatment group 400mg/kg. 
 Values are expressed as Mean ± SEM. 
 Values were find out by using ONE WAY ANOVA followed by 
Newman Keul’s multiple range tests. 
 *a values were significantly different from normal control (G 1) at 
(P<0.001) 
 *b values were significantly different from diabetic control (G 2) at 
(P<0.001) 
TABLE NO: 3 
Effect of administration of various doses of Neerizhivu chooranam on  
glycogen content (mg/gm tissue) of liver tissue of rats. 
GROUPS 
LIVER TISSUE GLYCOGEN CONTENT 
(mg/g tissue) 
GROUP I (G 1) 40.30 ± 2.32 
GROUP II (G 2) 8.23 ± 0.50*
a
 
GROUP III (G 3) 32.26 ± 1.60*
b
 
GROUP IV (G 4) 24.40 ± 1.10*
b
 
GROUP V (G 5) 26.82 ± 1.35*
b
 
G1- Normal Control; G2- Diabetic Control; G3- Positive control 
(Glipizide);  
G4- Treatment group 200mg/kg; G5- Treatment group 400mg/kg. 
 Values are expressed as Mean ± SEM. 
 Values were find out by using ONE WAY ANOVA followed by 
Newman Keul’s multiple range tests. 
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 *a values were significantly different from normal control (G 1) at 
(P<0.001) 
 *b values were significantly different from diabetic control (G 2) at 
(P<0.001) 
TABLE NO: 4 
Effect of administration of various doses of Neerizhivu chooranam on 
enzymes involved in carbohydrate metabolism in rats. 
GROUPS HEXOKINASE 
(µg/mg) 
GLUCOSE-6-
PHOSPHATE 
(µg/mg) 
GLUCOKINAS
E (µg/mg) 
GROUP I (G 1) 0.212 ± 0.014 0.396 ± 0.012 25.38 ± 1.40 
GROUP II (G 2) 0.094 ± 0.005*
a
 0.128 ± 0.008*
a
 4.90 ± 0.30*
a
 
GROUP III (G 3) 0.126 ± 0.008*
b
 0.320 ± 0.011*
b
 16.12 ± 0.96*
b
 
GROUP IV (G 4) 0.119 ± 0.004*
b
 0.265 ± 0.010*
b
 12.10 ± 0.52*
b
 
GROUP V (G 5) 0.142 ± 0.007*
b
 0.305 ± 0.012*
b
 14.20 ± 0.92*
b
 
G1- Normal Control; G2- Diabetic Control; G3- Positive control 
(Glipizide);  
G4- Treatment group 200mg/kg;      G5- Treatment group 400mg/kg. 
 Values are expressed as Mean ± SEM. 
 Values were find out by using ONE WAY ANOVA followed by 
Newman Keul’s multiple range tests. 
 *a values were significantly different from normal control (G 1) at 
(P<0.001) 
 *b values were significantly different from diabetic control (G 2) at 
(P<0.001) 
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TABLE NO: 5 
Effect of administration of various doses of Neerizhivu chooranam on 
haematological parameters. 
GROUPS WBC × 
103/µL 
RBC × 
106/µL 
HB % 
gm/dL 
PLATELET 
× 103/Ml 
GROUP I (G 1) 8.46 ± 0.62  6.52 ± 0.32 12.35 ± 0.62 312.42 ± 38.80 
GROUP II (G 2) 8.12 ± 0.70 6.90 ± 0.16 13.20 ± 0.42 295.20± 13.30 
GROUP III (G 3) 7.50 ± 0.40 6.52 ± 0.48 14.26 ± 0.40 280.23 ± 30.90 
GROUP IV (G 4) 7.20 ± 0.34 7.80 ± 0.22 12.95 ± 0.60 312.80 ± 18.92 
GROUP V (G 5) 8.76 ± 0.82 6.80 ± 0.36 11.72 ±0.60 314.42 ± 14.40 
G1- Normal Control; G2- Diabetic Control; G3- Positive control 
(Glipizide);  
G4- Treatment group 200mg/kg;   G5- Treatment group 400mg/kg. 
 Values are expressed as Mean ± SEM. 
 Values were find out by using ONE WAY ANOVA followed by 
Newman Keul’s multiple range tests. 
 Values were not significantly different from normal and diabetic 
control. 
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HISTOPATHOLOGY STUDY OF PANCREAS OF RATS 
 
Group I: Normal Control (Saline)  
 
Figure No: 1 
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The normal numbers and volume of the islets cells. 
Group II: Toxic Control (Alloxan monohydrate)  
 
 
Figure No: 2 
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The numbers of islets cells were significantly decreased, islets cells 
were severely swelled. 
Group III: Positive Control (Alloxan monohydrate + Glipizide)  
                                                Figure No: 3 
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The numbers of islets cells were moderatly decreased, islets cells were 
mildly swelled. 
Group IV: Treatment group (Alloxan monohydrate + Neerizhivu 
chooranam 200mg/kg) 
                                               Figure No: 4 
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The numbers of islets cells were moderate decreased, islets cells were 
moderate swelled. 
Group V: Treatment group (Alloxan monohydrate + Neerizhivu 
chooranam 400mg/kg) 
                                               Figure No: 5 
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The numbers of islets cells were moderate decreased, islets cells were 
moderate swelled. 
RESULTS 
Table No-1 shows the values of body weight of normal and 
experimental animals in each group. The mean body weight of diabetic 
rats (150.45 ±2.10) was significantly decreases as compared to normal 
animals (216.30 ± 4.58). 
The body weight of diabetic rats treated with Neerizhivu 
chooranam at different doses 200 mg/kg & 400 mg/kg was significantly 
increased to 226.30 ± 4.56 & 220.60 ± 4.23 respectively as compared to 
non-treated diabetic animals. In group III treated animals also showed an 
increase in body weight significantly as compared to diabetic rats. 
EFFECT OF NEERIZHIVU CHOORANAM ON BLOOD 
GLUCOSE LEVELS 
In all groups prior to alloxan administration the basal level of 
plasma glucose of the rats were not significantly higher in the rats 
selected for the study. In contrast non-diabetic control remained steadily 
euglycemic throughout the course of study. 
In pilot study (mild diabetics) the Table No-2 values show the 
effect of treatment of various doses of Neerizhivu chooranam at a dose of 
200 mg/kg & 400mg/kg respectively on plasma glucose levels. Blood 
glucose level was increased significantly to 172.20 ± 6.30 & 216.6 ± 7.28 
at 14
th
& 28
th
 day of treatment respectively, in the diabetic animals as 
compared to normal animals. 
In the Neerizhivu chooranam treated groups (both doses), 
significant anti-hyperglycemic (p<0.001) effect was evident from the 2
nd
 
week onwards, the decrease in blood sugar was maximum on completion 
of the 4
th 
week in the group receiving 200 mg/kg & 400mg/kg of 
Neerizhivu chooranam respectively, where as in group III treated animals 
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receiving glipizide at a dose of 10mg/kg also restored the blood sugar 
level near to normal range. 
EFFECT OF NEERIZHIVU CHOORANAM ON GLYCOGEN 
CONTENT 
 Glycogen content of liver tissue was estimated on the 28th day in 
non-diabetic control, diabetic control, treated group and positive control 
group as shown in Table No-3. In diabetic control liver glycogen content 
decreased significantly by 94.6 % as compared to non-diabetic control. 
Treatment with glipizide, Neerizhivu chooranam at two doses (200mg/kg 
& 400mg/kg) led to 73.39 %, 63.75 % and 67.33% increase in liver 
glycogen content in comparison to diabetic control. 
EFFECT OF NEERIZHIVU CHOORANAM ON HEPATIC 
ENZYMES 
 To establish diabetic, plasma glucose was determine 72hrs after 
alloxan administration. Only those rats with over 180 mg% were included 
in the study. On the 28
th
 day, hepatic enzymes Hexokinase & 
Glucokinase and substrate Glucose-6-phosphate were estimated in saline 
controls (group I), diabetic control (group II), and treatment controls 
(groups III, IV, V). 
 The result has been compiled in Table No-4. As compared to non-
diabetic control values, mean level of enzymes Hexokinase & 
Glucokinase and substrate Glucose-6-phosphate values decreased in 
diabetic control. The respective percentage decrease was 56.19%, 79.96% 
and 67.69% in diabetic control. Treatment with Neerizhivu chooranam at 
two doses (200mg/kg & 400mg/kg) for 28 days led to rise in percentage 
of these parameter by 28.26% & 82.53%, 127.45% & 34.28%,, 47.5%, 
67.78% respectively (P<0.001) as compared to diabetic control. Also 
treatment with glipizide 10mg/kg for 28 days led to rise in percentage of 
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these parameters by 38.04%, 138.09% and 188.93% respectively (P< 
0.001) as compared to diabetic control. 
EFFECT OF NEERIZHIVU CHOORANAM ON 
HAEMATOLOGICAL PARAMETERS  
 Table No: 5 values shows the haematological parameters of group 
I to group V treated animals. At the end of 28 days of the study period, no 
statistically significant differences were seen in the mean WBC and RBC 
counts, HB & Platelet values as compared to the non-diabetic animals. 
HISTOPATHOLOGICAL STUDY 
In histopathological study, the Figure-1 showed normal acini and 
normal cellular population in the islets of langerhans in pancreas of non-
diabetic rats (group-I). Figure-2 showed extensive damage and reduced 
number of islets of langerhans in pancreas of diabetic rats (group-II). 
Figure-3 showed restoration of normal cellular population size of islets 
with hyperplasia by glipizide (group-III). Figure-4 &5 showed partial 
restoration of normal cellular population and enlarged size of β-cells with 
hyperplasia in Neerizhivu chooranam treated groups (group IV & group 
V). 
DISCUSSION 
Currently available drug regimens for the management of diabetes 
mellitus have certain drawbacks
 [9] 
and therefore, there is a need for safer 
and more effective antidiabetic drugs. This study was therefore 
undertaken to assess anti-hyperglycemic property of Neerizhivu 
chooranam which have been reported in siddha to be useful in diabetes 
mellitus. 
In the current study diabetes mellitus was induced by alloxan 
monohydrate at a dose of 150 mg/kg i.p. Alloxan causes enormous 
reduction in insulin release through the destruction of β cells of the islets 
of langerhans. The mechanism of alloxan action was completely 
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described elsewhere.
[10,11]
 In our study we have observed a significant 
increase in plasma glucose level in alloxan induced diabetic rats, whereas 
treatment with glipizide (10mg/kg), Neerizhivu chooranam at two 
different doses (200mg/kg & 400mg/kg) showed significant 
antihyperglycemic activity in mild degree of hyperglycemia. In mild 
diabetes, the maximum percent reduction in glucose level was seen in 
groups receiving 400mg/kg per day of Neerizhivu chooranam. This could 
be due to potentiation of insulin effect of plasma by increasing their 
pancreatic secretion of insulin from existing β-cells of islets of langerhans 
or its release from bound insulin. The significant and consistent 
antidiabetic effect of Neerizhivu chooranam in alloxan-induced diabetic 
rats in also is due to enhanced glucose utilization by peripheral tissues. 
The above finding is correlated with an earlier study, which reported that 
the water extract of dried fruits of Terminalia chebula
[12]
 improves 
glucose tolerance and bring down fasting blood glucose in diabetic rats. 
 The body weights were decreased in alloxan-induced diabetic rats.
 
[13]
Administration of Neerizhivu chooranam at two doses increased body 
weight in alloxan-induced diabetic rats. The ability of Neerizhivu 
chooranam to protect massive body weight loss seems to be due to its 
ability to reduce hyperglycemia. 
 As reported earlier,
[14]
 in the current study  the liver glycogen 
content was reduced significantly in diabetic control as compared to non-
diabetic control. Treatment with Neerizhivu chooranam at two doses 
prevented this alteration in glycogen content of liver tissue. But could not 
normalize the content of glycogen of the non-diabetic control. This 
prevention of depletion of glycogen in liver is possibly due to either 
stimulation of insulin release from β-cells 
[15]
 or due to the 
insulinomimetic activity of some components of the plants resulting in 
direct peripheral glucose uptake. 
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 Decreased enzymatic activity of hexokinase, glucokinase and 
substrate glucose-6- phospate has been reported in diabetic animals 
resulting in depletion of liver and muscle glycogen.
[16]
The present study 
also had similar results. Treatment with Neerizhivu chooranam 
significantly increased the hexokinase & glucokinase activity and 
glucose-6-phosphate level in the liver, indicating an overall increase in 
glucose influx thus Neerizhivu chooranam seems to have an overall effect 
in increase in glucose utilization. Studies also assess this plant extract 
showed no adverse effect on haematological parameters including WBC 
and RBC counts, HB, Platelets. Thus this Neerizhivu chooranam can be 
presumed to be free from toxicological effects. 
 Histopathological studies revealed that Neerizhivu chooranam and 
Glipizide significantly improved the histological architecture of the islets 
of langerhans. The groups treated with Neerizhivu chooranam (200mg/kg 
& 400mg/kg) and glipizide (10mg/kg) showed greater persistence of 
islets of langerhans & lesser degree of necrotic changes as compared to 
the untreated alloxan-induced diabetic rats. 
CONCLUSION 
The Neerizhivu chooranam did not show a consistent effect on 
normal blood sugar levels, but it effectively reversed the Alloxan induced 
changes in the blood sugar level and β-cell population in the pancreas. It 
also showed a protective effect when it was given earlier to alloxan 
administration. The action of Neerizhivu chooranam on the pancreatic β-
cells and the absence of toxicity may offer a new hope to the diabetes in 
future. 
 From the above discussion it concluded that the Neerizhivu 
chooranam at high dose (400mg/kg) & low dose (200mg/kg) exhibited 
significant anti-hyperglycemic activity. This Neerizhivu chooranam  also 
showed improvement in the parameters like body weight, liver glycogen 
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content and carbohydrate metabolizing enzymes, as well as regeneration 
of β-cells of pancreas and so might be of value in diabetes treatment.  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1.Name___________ 2.Age_____3.gender_________4.Phone no  _________ 
5. OP No. 6. IP No. 7. S.No.   
. INCLUSION CRITERIA:                                      
 Age 35-65 yrs 
 Polyuria  
 Polydipsia 
 Polyphagia 
 Constipation 
 Weight loss 
 General  tiredness, Burning feet, generalized/genital pruritus, , tingling and 
numbness, delayed/non-healing wounds/ulcer,.  
 Hyperglycemia (Blood glucose level ≥ 125 mg/dl in fasting, ≥ 170 mg/dl in 
postprandial). 
 Patient willing to sign the informed consent stating that he  will 
conscientiously stick to the treatment during 20 days but can opt out of the 
trial of his  own conscious discretion. 
 Patients who are willing to provide blood and urine for lab investigation. 
EXCLUSION CRITERIA:        
 Diabetic complications like neuropathy, retinopathy, etc. 
 Hypertension 
 Heart disease 
 Kidney disease 
 Liver diseases 
 Pancreatic disease like acute pancreatitis, carcinoma of pancreas etc… 
 Gestational diabetes 
 Pregnancy and Lactation 
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 Patient not willing to give blood sample 
 
DATE: 
STATION 
 
                                                                                     SIGNATURE OF  HOD 
SIGNATURE OF INVESTIGATOR 
 
 SIGNATURE OF LECTURER  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM l A      - 
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _______________                           2. OP/IP No:---------- 
 
       
3. Name: ________________                                                    4. Gender:   
Female/male 
 
 
5. Age (years): _________   DOB            
 
      Date       Month            Year 
 
6.Address:-------------------------------------- 
                     ------------------------------------- 
                    -------------------------------------- 
 
 
7.A.Occupation:    -----------------------------                         B. Nature of work-----------
------ 
 
 
8. Educational  Status:   A) Illiterate                  B)Literate          
 
 
9.Height:         cms                10.Weight:         kg 
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11. Complaints and Duration:   
 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
 
 
 
12. Habit of 
 
A) Smoking                1. Yes; duration ________ years;    Number-   ….       2. No   
 
B) Alcoholism            1. Yes; duration ________ years;    Quantity-    . ... ml       2. No   
 
C) Tobacco chewing   1. Yes; duration ________ years                                         2.No      
 
D) Betel chewing       1. Yes; duration ________ years                                         2.No 
 
13.Dietary style:    A.Pure vegetarian             B.Non-vegetarian     C.      C. Mixed diet 
 
14. Drug History: Had the patient been treated before with allopathy drug?  
 
                                                        A) Yes               2) No 
                                     
15 MARITAL STATUS    1.Married   2.Unmarried  
                                                 
16. FAMILY HISTORY 
 
Whether this problem runs in family?            1. Yes                     2.No   
  
132 
 
       If yes, mention the relationship of affected person(s)         - ------------------------- 
                                                                                           ------------------------- 
 
17. MENSTRUAL HISTORY:      
 
 
 
18. BOWEL HABITS & MICTURITION:      Normal  
 
            History of habitual constipation              1.Yes                      2.No                                                      
 
            History of frequent diarrhoea                  1.Yes                      2.No                                                       
 
            History of frequent dysuria                      1.Yes                      2.No                
 
19. PSYCHOLOGICAL STATE 
                   
            Normal                                          Anxiety                                       Depression 
 
 
 
 
  Date:  
 
       
  Station: 
 
 
Signature of the Investigator: 
 
 
Signature of the Lecturer:                                                        Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
 
FORM II & II-A 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S NO -----------                                     
 
2. OP/IP NO ---------                 
 
3. NAME --------------- -------------                 
 
4. GENDER ------- 
 
5. DATE OF  ASSESSMENT   :    ---------------------- 
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SIDDHA SYSTEM OF EXAMINATION 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
 0st 
day 
07
th 
day
 
14
th 
Day
 
21
th 
 day 
28
th
  
Day 
35
th
 
Day 
42
th
 
Day 
45
th
 
Day 
Vali         
Azhal         
Iyyam         
Vali 
Azhal 
        
Azhal 
vali 
        
 Iyya 
vali 
        
 Vali 
Iyyam 
        
 Azhal 
Iyyam 
        
 Iyya 
Azhal 
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 II. NAA:[TONGUE] 
 
 
 
 
 0st 
day 
07th 
day 
14th 
Day 
21th 
 day 
28th  
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Colour Dark     /     
Yellow 
Red      /     
Pale 
Dark/Yellow/ 
Red/Pale 
Dark/Yellow/ 
Red/Pale 
Dark/ 
Yellow/ 
Red/Pale 
Dark/Yellow 
Red/Pale 
Dark/ 
Yellow 
Red/Pale 
Dark/ 
Yellow 
Red/Pale 
Dark/ 
Yellow 
Red/Pale 
Taste Sweet/Bitter
/Sour 
Pungent/ 
None 
Sweet/Bitter/ 
Sour 
Pungent/None 
Sweet/Bitter/ 
Sour 
Pungent/None 
Sweet/Bitter/ 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour 
Pungent/
None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/Absent Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/Absent Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/Absent Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/Absent Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
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III.NIRAM: [COMPLEXION]    
0st 
day 
07th 
day 
14th 
Day 
21th 
 day 
28th  
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Dark/ 
Yellow 
tinted/ 
Pale 
Dark/ 
Yellow  
tinted  / 
Pale 
Dark/ 
Yellow  
tinted / 
Pale 
Dark/  
Yellow  
tinted / Pale      
Dark/  
Yellow  
tinted/ Pale 
Dark/  
Yellow  
tinted/ 
Pale 
Dark/  
Yellow  
tinted/ 
Pale 
Dark/  
Yellow  
tinted/ 
Pale 
 
 
IV.MOZHI: [VOICE] 
 
0st 
day 
07th 
day 
14th 
Day 
21th 
 day 
28th  
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Medium/ 
High 
Low 
pitched 
Medium/ 
High/ 
Low 
pitched 
Medium/ 
High/ 
Low 
pitched 
Medium/ 
High/ 
Low 
pitched 
Medium/ 
High/ 
Low 
pitched 
Medium/ 
High 
Low 
pitched 
Medium/ 
High/ 
Low 
pitched 
Medium/ 
High 
Low 
pitched 
 
 
V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
   
0st 
day 
07th 
day 
14th 
Day 
21th 
 day 
28th  
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Dark/ 
Yellow 
Red/ 
Pale 
Dark/ 
Yellow 
Red/ 
Pale 
Dark/ 
Yellow 
Red/ 
Pale 
Dark/ 
Yellow 
Red/ 
Pale 
Dark/ 
Yellow 
Red/ 
Pale 
Dark/ 
Yellow 
Red/ Pale 
Dark/ 
Yellow 
Red/ Pale 
Dark/ 
Yellow 
Red/ Pale 
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VI. MALAM; [BOWEL HABITS / STOOLS] 
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Colour Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/Pale 
Dark/ 
Yellow/ 
Red/Pale 
Dark/ 
Yellow/ 
Red/Pale 
Dark/ 
Yellow/ 
Red/Pale 
Dark/ 
Yellow/ 
Red/Pale 
Consisten
cy 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid 
/Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Stool  
bulk              
Normal/ 
Reduced 
 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipat
ion   
Present/Ab
sent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/Ab
sent 
 
Present 
/Absent 
 
Present 
/Absent 
 
Present 
/Absent 
 
Present 
/Absent 
 
Diarrhoea Present/Ab
sent 
Present/ 
Absent 
Present/ 
Absent 
Present/Ab
sent 
Present 
/Absent 
Present 
/Absent 
Present 
/Absent 
Present 
/Absent 
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VII. URINE EXAMINATION:    
 
 
 
 
 
 
 
 
 
 
 
 
 
NEER 
KURI 
0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Niram 
[Colour]   
White/ 
Yellowish/ 
Strawcolou
red/ 
Crystal 
clear 
White/Ye
llowish/ 
Strawcol
oured 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw  
coloured/ 
Crystal clear 
Manam 
[Odour] 
Present  
Absent 
 Present  
Absent 
Present  
Absent 
Present  
Absent 
Present  
Absent 
Present  
Absent 
Present  
Absent 
Present  
Absent 
Nurai 
[Froth] 
Nil 
Reduced 
/Increased 
Nil 
Reduced/
Increased 
Nil 
Reduced/ 
Increased 
Nil 
Reduced 
/Increased 
Nil 
Reduced/ 
Increased 
Nil 
Reduced/ 
Increased 
Nil 
Reduced/ 
Increased 
Nil 
Reduced/ 
Increased 
Edai 
[Sp.gra]          
Normal 
Increased/
Reduced 
Normal 
Increased
/Reduced 
Normal 
Increased/ 
Reduced 
Normal 
Increased/ 
Reduced 
Normal 
Increased/ 
Reduced 
Normal 
Increased 
/Reduced 
Normal 
Increased/ 
Reduced 
Normal 
Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Volume   Normal 
Increased/
Reduced 
Normal 
Increased
/Reduced 
Normal 
Increased/R
educed 
Normal 
Increased/R
educed 
Normal 
Increased/R
educed 
Normal 
Increased/Redu
ced 
Normal 
Increased/Redu
ced 
Normal 
Increased 
/Reduced 
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NEIKURI 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Serpentine fashion         
Annular/Ringed 
fashion 
        
Pearl beaded 
fashion    
        
Mixed fashion         
Other fashion         
 
VIII. SPARISAM: [PALPATORY  PERCEPTION] 
 
0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Warmth/Cold 
 Sweat 
Warmth/ 
Cold 
Sweat 
Warmth/ 
Cold 
Sweat 
Warmth/ 
Cold 
Sweat 
Warmth/ 
Cold 
Sweat 
Warmth/ 
Cold 
Sweat 
Warmth/ 
Cold 
Sweat 
Warmth/ 
Cold 
Sweat 
 
5. THEGI: [ TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
6.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
  Kurinji                         Mullai                  Marutham              Neithal                  Palai 
(Hilly terrain)              (Forest range)          (Plains)                  (Coastal belt)        (Arid 
regions)  
 7. KAALAM 
Kaarkalam-                                 Pinpanikalam      
Koothirkalam-                            Ilavenil 
Munpanikalam -                         Muthuvenil 
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8. GUNAM 
Sathuvam                        Rasatham                       Thamasam 
9. IMPORIGAL (SENSORY ORGANS) 
 
10. KANMENDRIYAM ( MOTOR ORGANS) 
 
 
 
 
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Mei (Skin)         
Vai 
(Buccal Cavity) 
        
Kann (Eye)         
Sevi (Ear)         
Mooku (Nose)         
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Kai (upper 
limb) 
        
Kaal (lower 
limbs ) 
        
Vai   (buccal 
cavity) 
        
Eruvai 
(excretory 
organs) 
        
Karuvai  
(reproductive 
organs) 
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11. KOSANGAL(Sheath)   
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Annamaya 
 Kosam 
        
Pranamaya 
kosam  
        
Manomaya 
kosam  
        
Vignanamaya 
kosam  
        
Ananthamaya 
kosam  
        
 
12. MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
A)VATHAM: 
 
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Praanan         
Abaanan
  
        
Samaanan         
Udhaanan         
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Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeya         
 
 
B) PITHAM:   
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Analapitham 
  
        
 Prasakam         
Ranjakam         
Aalosakam         
Saathakam         
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C) KABAM: 
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam             
Santhigam          
 
13. SEVEN DHATHUS: (7 SOMATIC COMPONENTS)  
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Saaram[Chyme]         
Senneer[Blood]          
Oon[Muscle]         
Kozhuppu[Fat]         
Enbu[Bones]         
Moolai 
[Bonemarrow] 
        
Sukkilam/Suron
itham [Genital 
discharges] 
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14. SYSTEMIC EXAMINATION: 
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
LOCOMOTOR 
SYSTEM 
        
CARDIO 
VASCULAR  
SYSTEM 
 
 
       
RESPIRATORY 
SYSTEM      
 
 
       
GASTRO 
INTESTINAL 
 SYSTEM    
 
 
       
CENTRAL  
NERVOUS  
SYSTEM        
 
 
       
UROGENITAL 
SYSTEM 
        
ENDOCRINE  
SYSTEM 
        
 
15. GENERAL EXAMINATION: 
 0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
Height (cms)         
Weight (kg)         
Temperature(°F)            
Pulse rate (pe rmin)         
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Heart rate (per min)         
Respiratoryrate(permin)         
Blood 
pressure(mm/Hg) 
        
Pallor         
Jaundice         
Cyanosis         
Lymphadenopathy         
Pedal edema         
Clubbing         
Jugular vein pulsation         
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16. CLINICAL SYMPTOMS 
S.NO CLINICAL  
SYMPTOMS 
0st 
day 
07th 
day 
14th 
Day 
21th 
day 
28th 
Day 
35th 
Day 
42th 
Day 
45th 
Day 
1. POLY UREA          
2. Polydypsia          
3. Polyphagia          
4. Nocturia          
5. Tiredness          
6. Pain in the limbs          
7. Pain &burning 
sensation in the 
both sole  
        
8. Parasthesia in 
the feet 
        
9. Pruritis vulvae          
10. Balanitis         
11 Asymptomatic          
 
Date :      
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                        Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
 
FORM III 
LABORATORY PARAMETERS-CHART 
 
 
1. O.P.No / I.P.No: ____________        
 
2. Bed No: _____  
   
        3.. S.No: _____    
 
      4. Name: ___________________________  
 
       5. Age (years): _____ 
 
         6. Gender:           M                    F  
   
LAB INVESTIGATION CHART     
BLOOD INVESTIGATION 
NORMAL 
VALUES 
BEFORE 
TMT 
(with 
date) 
AFTER 
TMT(WITH 
DATE) 
 
HB( gms%) 
M:12-15 
W:11.5-14 
  
 
T.RBC(milli/cu.mm) 
M:4.0-5.5 
W:3.5-4.5 
  
 ½ hr. -   
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ESR (mm /hr) 
1 hr. 
M:6-12 
W:7-18 
  
 
T.WBC(cells  /cu.mm) 
 
4000-10000 
  
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocutes 20-40   
Monocytes 2-10   
Esonophils 1-6   
Basophiles 0-1   
Blood group  
Rh type  
 
Blood Investigation 
Normal 
Values 
Before 
TMT(with 
Date) 
After TMT 
(With 
Date) 
Platelets ;(lak/ cubic mm) 
1,50000-
500000 
  
Blood 
glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Random 80-120   
Lipid 
profile 
(mg/dl) 
Serum cholesterol 150-200   
HDL 30-63   
LDL Upto 130   
VLDL 40   
TGL Upto 160   
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
Serum Uric acid 
M:3-9 
W: 2.5-7.5 
  
LFT 
(mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-1.2   
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Indirect bilirubin 0.2-0.7   
Serum total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.6   
Fibrinogen(g/dl) 0.2-0.4   
Serum calcium 8.5-10.5   
Serum phosphorous 3-4.5   
SGOT (IU/L) 0-40   
SGPT (IU/l) 0-35   
Alkaline phosphatase 
(kingÅ units) 
80-290 
 
  
 
Urine investigation 
Before TMT(with 
Date) 
After TMT (With 
Date) 
Neer kuri   
Niram   
Manam   
Nurai   
Edai   
Enjal   
Nei kuri  :-   
Albumin   
 Sugar(F)   
Sugar(PP)   
Sugar( R)   
Deposits   
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Bile salts   
Bile pigments   
Urobilinogen   
 
Date: 
 
Station:         
 
 
 
SIGNATURE  OF  INVESTIGATOR                                                  SIGNATURE  OF   HOD 
          
                      
SIGNATURE  OF LECTURER 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM IV 
PATIENT  INFORMATION SHEET 
 
• It is a Hereditary disease. 
• This disease is not contagious. 
• It is a  clinical syndrome occurs due to deficiency of Insulin secretion. 
• Many herbal and mineral siddha medicines are currently practiced by the 
siddha practioners for Diabetes mellitus. 
• The trial drug is recommended for this disease, specially by the Doctors of 
GSMC. 
• The trial drug is prepared at the Gunapadam lab of government siddha medical 
college & hospital,palayamkottai, under the   direct supervision of teaching 
faculties of   Maruthuvam and Gunapadam. 
 
Details of the trial drug: 
             
1. . NEERIZHIVU CHOORANAM 
                 DOSAGE :  2gm, two times a day; after food 
                ADJUVANT : Butter milk  
                    Duration : 45 days . 
 
 Patients are advised to addup green vegetables, ,  greens , protein foods, fibre 
foods, wheat .Patients must walk 30-45 minutes per day 
  Patients are advised to avoid tamarind, betel chewing, tobacco , alcohol and 
smoking. 
                              
                                        
152 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
CONSENT FORM-IV A 
Certificate by Investigator I certify that I have disclosed all details about the study in 
the terms readily understood by the patient. 
Date: ……………..      Signature: …………………………. 
  Name: ……………………….. 
Consent by Patient 
              I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
    I am aware of my right to opt out of the trial at any time during the course of the 
trial without having to give the reasons for doing so. 
      I, exercising my free power of choice, hereby give my consent to be included        
             As a subject in the clinical trial of NEERIZIVHU CHOORANAM for the 
management of MADHUMEGAM ( DIABETES MELLITUS) 
. 
Date: ………………..   Signature: 
………………………………… 
Name: ………………………………………….. 
Date: ……………….    Signature of Witness: …………………… 
Name………….. ……………   
                                                                        Relationship: ………………………… 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM IV B 
DIETARY ADVICE FORM 
DIET ADVICE: 
• Avoid sweets, fruits, tubers, ghee, milk, oily foods, non-vegetarian foods, 
alcohol, smoking, tobacco, betel nut.  
• Take tender fresh vegetables, fiber content vegetables, greens, butter milk and 
take bitter gourd, ivy gourd, plantain flower weekly twice. 
• Brish walking for 45 minutes daily.  
 
Kelvaragu (Raagi)     Thuthuvalai (Climbing Brinjal) 
Sirukeerai (Amaranthus)    peerkku (Ridged gourad) 
Murungai Poo      Eraal 
Gothumai (Wheat)     Athipinchu (Cluster fig) 
Ponnanganni (Sessile plant)    Venthayam (Greek hayes) 
Pagal (Bitter gourad)     Murungai (House radish) 
Pudal (Snake gourad)     Ellu (Gingelly) 
Avarai (The tanners cassia)    Sirupayaru (Green gram) 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM IV C 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD number: __________ 
Age: ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
• Long absence at reporting :   Yes/ No 
• Irregular treatment:    Yes/ No 
• Shift of locality :     Yes/No 
• Increase in severity of symptoms:  Yes/No 
• Development of severe adverse drug reactions: Yes/No 
      Date: 
              
       SIGNATURE  OF  INVESTIGATOR                                     SIGNATURE  OF   HOD 
          
                      
      SIGNATURE  OF LECTURER 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM  IV  D 
ADVERSE DRUG REACTION FORM 
 
Name: ________________________       OPD/ IPD number: __________ 
Age: ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: 
 
Date: 
Station: 
 
        
SIGNATURE  OF  INVESTIGATOR                                                SIGNATURE  OF   HOD 
          
                      
SIGNATURE  OF LECTURER 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE – II RANDOMIZED OPEN CLINICAL STUDY 
ON MADHUMEGAM (TYPE 2 DIABETES MELLITUS) WITH 
NEERIZHIVU CHOORANAM 
FORM IV –E 
(DRUG COMPLIANCE FORM) 
 
 Name: Age / sex  Serial no  
OPD/IPD No Date  Bed no 
 
Name Of The Drug : NEERIZIVHU CHOORANAM 
 Drugs issued date:  
 Drugs returned date 
S.NO DATE 
DRUG TAKEN TIME 
MORNING/TIME EVENING/TIME 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
Day 8    
Day 9    
Day 12    
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  MORNING/TIME EVENING/TIME 
Day13    
Day14    
Day15    
Day16    
Day17    
Day18    
Day19    
Day20    
Day21    
Day22    
Day23    
Day24    
Day25    
Day26    
Day27    
Day28    
Day29    
Day30    
Day31    
Day32    
Day33    
Day34    
Day35    
Day36    
Day37    
Day38    
Day39    
Day40    
Day41    
Day42    
Day43    
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Date 
 
Station 
 
SIGNATURE  OF  INVESTIGATOR                                       SIGNATURE  OF   HOD 
          
                      
SIGNATURE  OF LECTURER 
 
 
 
 
 
 
 
 
Day44    
Day45    
BIBLIOGRAPHY 
SIDDHA  LITERATURES 
Agasthiyar vaidya kaviyam 1500 
Agasthiyar ayul vedam 1200 
Agasthiyar kanma kandam 300 
Agasthiyar gurunaadi 
Athamaratsamirtham @ vaithyasara sankarakam 
Yugivaidya chinthamani 800 
Noinadal Vol i&ii – Dr.M.Shanmugavelu 
Sitha Maruthuvam – Kuppusamy mudhaliyar 
Udal thathuvam  I & II– Dr.Venugopal 
Therayar Neerkuri and neikkuri  
Noigalukku siddha parikaram – Dr.M.Shanmugavelu 
Noyillaa neri –Dr.K.Durai raasan 
Therayar karisal 
Therayar vagadam 
Guna padam – Mooligai .S.Murugesa muthaliyar 
Yugimuni vaidya kaviyam 
Materia medica – Nadkarni I &II  
T.V.Sambashivam pillai dictionary  
Indigenous drugs of India-Chopra 
Wealth of India 
Yoga for diabetes - Dr.S.Sri Kanta 
Sarabendra Vaidhya Muraigal – Neerizhivu Cgitchai – Dr. S. Venkatarajan 
MODERN LITERATURES 
Gray’s anatomy 
Guyton’s Textbook of physiology 
Fundamentals of Bio chemistry – Ambika Shunmugam  
Robbin’s Pathologic basis of disease 
Hutchisons clinical methods 
Harrison’s principles of internal medicine  
Davidson’s principles and practice of medicine 
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